{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":321,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":321,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"35fb7377424e","filters":{"venue":"HemaSphere"}},"results":[{"id":"W4308963956","doi":"10.1097/hs9.0000000000000801","title":"Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saint John Regional Hospital; University of New Brunswick","funders":"Janssen Biotech; Novo Nordisk; Ascentage Pharma; Servier; Moderna; Celltrion; Incyte; Pharmacyclics; MEI Pharma; Karyopharm Therapeutics; Gilead Sciences; BeiGene; Sanofi; Cilag; TG Therapeutics; Pfizer; MorphoSys; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Internal medicine; Bendamustine; Chronic lymphocytic leukemia; Tolerability; Ofatumumab; Gastroenterology; Adverse effect; Oncology; Leukemia","authors":[{"name":"Paolo Ghia","is_ca":false},{"name":"Andrzej Pluta","is_ca":false},{"name":"Małgorzata Wach","is_ca":false},{"name":"Daniel Lysák","is_ca":false},{"name":"Martin Šimkovič","is_ca":false},{"name":"Iryna Kriachok","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Sean Dolan","is_ca":true},{"name":"Philip Campbell","is_ca":false},{"name":"Gerardo Musuraca","is_ca":false},{"name":"Abraham Jacob","is_ca":false},{"name":"Eric J. Avery","is_ca":false},{"name":"Jae Hoon Lee","is_ca":false},{"name":"Ganna Usenko","is_ca":false},{"name":"Min Hui Wang","is_ca":false},{"name":"Ting Yu","is_ca":false},{"name":"Wojciech Jurczak","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07152014511977556,"gpt":0.3352977625918449,"spread":0.2637776174720693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003067108,0.00103748,0.001298889,0.00037114,0.0003578707,0.001039945,0.0007106491,0.0009222742,0.003835111],"category_scores_gemma":[0.002181548,0.000201818,0.001642543,0.0003246769,0.0005380264,0.0009178388,0.000377803,0.002539306,0.0006079681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006446535,"about_ca_system_score_gemma":0.000706516,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006558932,"about_ca_topic_score_gemma":0.002261044,"domain_scores_codex":[0.9991634,0.00054248,0.00003450468,0.00007159763,0.0000731846,0.0001148918],"domain_scores_gemma":[0.9989391,0.0003323964,0.0002015089,0.00008727877,0.00008398819,0.0003557499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8855607,0.006466113,0.003724333,0.001035167,0.002232442,0.0001722892,0.0001442167,0.001795203,0.004512187,0.0006612543,0.0165035,0.07719271],"study_design_scores_gemma":[0.840817,0.1182586,0.01597054,0.0002089974,0.002174356,0.0003635179,0.00008014902,0.003222905,0.002110235,0.001356306,0.01537998,0.00005737527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9603305,0.01568561,0.0007085351,0.001917869,0.000449362,0.001669215,0.004795744,0.0002325124,0.01421063],"genre_scores_gemma":[0.9771673,0.004404396,0.001463859,0.001791099,0.0006708811,0.001745425,0.008030199,0.00004569707,0.004681114],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003835111,"threshold_uncertainty_score":0.01622063,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2974616558","doi":"10.1097/hs9.0000000000000286","title":"Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report","year":2019,"lang":"en","type":"review","venue":"HemaSphere","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Intensive care medicine; Normality; Pathological; Disease; Systematic review; MEDLINE; Pathology; Psychiatry","authors":[{"name":"Francesco Rodeghiero","is_ca":false},{"name":"Ingrid Pabinger","is_ca":false},{"name":"Margaret V. Ragni","is_ca":false},{"name":"Rezan A. Kadir","is_ca":false},{"name":"Erik Berntorp","is_ca":false},{"name":"Victor S. Blanchette","is_ca":true},{"name":"Imre Bodó","is_ca":false},{"name":"Alessandro Casini","is_ca":false},{"name":"Paolo Gresele","is_ca":false},{"name":"Riitta Lassila","is_ca":false},{"name":"Frank W.G. Leebeek","is_ca":false},{"name":"David Lillicrap","is_ca":true},{"name":"Diego Mezzano","is_ca":false},{"name":"Patrizia Noris","is_ca":false},{"name":"Alok Srivastava","is_ca":false},{"name":"Alberto Tosetto","is_ca":true},{"name":"Jerzy Windyga","is_ca":false},{"name":"Barbara Zieger","is_ca":false},{"name":"Nigel S. Key","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1192130332945532,"gpt":0.3737422878019674,"spread":0.2545292545074142,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1030642,0.001734267,0.003097716,0.01170415,0.002733724,0.007651179,0.008976674,0.009425754,0.005219415],"category_scores_gemma":[0.1016714,0.001307203,0.005417184,0.006429285,0.004792321,0.006890101,0.009484472,0.01609373,0.005365295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009159378,"about_ca_system_score_gemma":0.04573351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009847415,"about_ca_topic_score_gemma":0.01033689,"domain_scores_codex":[0.9349034,0.02775515,0.02008642,0.003037231,0.01177727,0.002440567],"domain_scores_gemma":[0.8785425,0.03157724,0.007805591,0.004391595,0.06876964,0.008913487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001063081,0.0002284382,0.002451063,0.0137538,0.0002427414,0.0008486824,0.003483321,0.001009678,0.0009457977,0.04799999,0.5867574,0.3421728],"study_design_scores_gemma":[0.00009897192,0.0001045592,0.00357983,0.04400168,0.0002220663,0.001565891,0.002087444,0.0007957377,0.0003776214,0.03636192,0.9106564,0.0001478397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.001842816,0.2509046,0.08923989,0.5831507,0.04591286,0.004720393,0.002043125,0.0007507766,0.02143491],"genre_scores_gemma":[0.03469444,0.2482215,0.4870073,0.1672934,0.02538235,0.01166344,0.009546649,0.0005498156,0.01564107],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.1030642,"threshold_uncertainty_score":0.545062,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3129688332","doi":"10.1097/hs9.0000000000000540","title":"Hemophilia Gene Therapy: Approaching the First Licensed Product","year":2021,"lang":"en","type":"review","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Genetic enhancement; Clinical trial; Medicine; Intensive care medicine; Gene; Biology; Internal medicine; Genetics","authors":[{"name":"Paul Batty","is_ca":true},{"name":"David Lillicrap","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1062999990702083,"gpt":0.3599660407400558,"spread":0.2536660416698476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001082495,0.0006602662,0.001057806,0.001810209,0.0002701395,0.001515998,0.0007700256,0.001829711,0.00502886],"category_scores_gemma":[0.001014846,0.0002769589,0.0004691424,0.001221868,0.000609322,0.002652282,0.0006998042,0.003017546,0.003002777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007487126,"about_ca_system_score_gemma":0.00137276,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008387024,"about_ca_topic_score_gemma":0.001323046,"domain_scores_codex":[0.9997122,0.00005820989,0.00003430308,0.00004132257,0.0001308056,0.00002304817],"domain_scores_gemma":[0.999585,0.0002371247,0.00004609485,0.00001084276,0.00008853027,0.00003244768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008470543,0.0000689865,0.00009515307,0.01810175,0.00004541809,0.0003154666,0.0001236486,0.0003643189,0.004325795,0.01521509,0.04918533,0.9120743],"study_design_scores_gemma":[0.00001055661,0.00007888157,0.0001608588,0.003101019,0.00003332696,0.0008001305,0.00004836833,0.00006507534,0.0004685226,0.002291108,0.9929329,0.000009231741],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001237909,0.9967955,0.000226329,0.0006459289,0.0003001095,0.000005561279,0.00001733473,0.000009516717,0.001875943],"genre_scores_gemma":[0.0006113619,0.9976594,0.0002710125,0.0004171337,0.0001822678,0.000007220557,0.00002113035,0.000002801147,0.0008276078],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00502886,"threshold_uncertainty_score":0.01682323,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4400982166","doi":"10.1002/hem3.136","title":"Long‐term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM‐3 study","year":2024,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Pfizer","keywords":"Multiple myeloma; Term (time); Refractory (planetary science); Medicine; Oncology; Internal medicine; Biology; Physics","authors":[{"name":"Michael H. Tomasson","is_ca":false},{"name":"Shinsuke Iida","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Mohamad Mohty","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Guenther Koehne","is_ca":false},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"H. Miles Prince","is_ca":false},{"name":"Andrea Viqueira","is_ca":false},{"name":"Eric Leip","is_ca":false},{"name":"Umberto Conte","is_ca":false},{"name":"Sharon T. Sullivan","is_ca":false},{"name":"Alexander M. Lesokhin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01670397617652239,"gpt":0.2747062140453024,"spread":0.25800223786878,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005818175,0.0004557833,0.001687155,0.0005588748,0.00025805,0.001736381,0.0008592854,0.0008175506,0.0009984919],"category_scores_gemma":[0.004313811,0.0002097626,0.001399698,0.001342463,0.0003698202,0.001057074,0.0004714217,0.001982045,0.0004522611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001218965,"about_ca_system_score_gemma":0.001044361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001240469,"about_ca_topic_score_gemma":0.003007991,"domain_scores_codex":[0.9989461,0.0003145399,0.0001849268,0.0001009346,0.0003722026,0.0000812668],"domain_scores_gemma":[0.9944316,0.002051522,0.001816872,0.0002498784,0.0009813713,0.0004688775],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0256646,0.0009715789,0.08209835,0.002960229,0.003452492,0.0002870295,0.0003384424,0.001858359,0.005422324,0.0008270679,0.03194026,0.8441792],"study_design_scores_gemma":[0.01021125,0.0261524,0.5486937,0.00283839,0.01415086,0.002466141,0.0003099836,0.003830648,0.006431647,0.001866629,0.3828201,0.000228319],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3759412,0.5893108,0.003028327,0.01089994,0.0008576934,0.0002897845,0.00876103,0.0002461989,0.0106651],"genre_scores_gemma":[0.7792381,0.174295,0.004341158,0.01732462,0.003331185,0.0005780876,0.01872036,0.0001663483,0.002005056],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005818175,"threshold_uncertainty_score":0.03076982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379467996","doi":"10.1097/hs9.0000000000000900","title":"Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Antithrombotic; Hemostasis; Thrombosis; Atrial fibrillation; Clotting factor; Stroke (engine); Venous thrombosis; Intensive care medicine; Internal medicine; Physical therapy","authors":[{"name":"Roger E. G. Schutgens","is_ca":false},{"name":"Víctor Jiménez‐Yuste","is_ca":false},{"name":"Miguel A. Escobar","is_ca":false},{"name":"Anna Falanga","is_ca":false},{"name":"Bruna Gigante","is_ca":false},{"name":"Robert Klamroth","is_ca":false},{"name":"Riitta Lassila","is_ca":false},{"name":"Frank W.G. Leebeek","is_ca":false},{"name":"Michael Makris","is_ca":false},{"name":"Tarek Owaidah","is_ca":false},{"name":"Michelle Sholzberg","is_ca":true},{"name":"Andreas Tiede","is_ca":false},{"name":"David J. Werring","is_ca":false},{"name":"H. Bart van der Worp","is_ca":false},{"name":"Jerzy Windyga","is_ca":false},{"name":"Giancarlo Castaman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05393970505194876,"gpt":0.3947387255850169,"spread":0.3407990205330681,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004468486,0.0007313169,0.001362943,0.002230108,0.0006581136,0.002236376,0.002132136,0.006262091,0.01468289],"category_scores_gemma":[0.01891912,0.0004085273,0.002188495,0.001507938,0.0005333137,0.001333925,0.001834215,0.00404362,0.01042655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002316528,"about_ca_system_score_gemma":0.007230758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01068169,"about_ca_topic_score_gemma":0.01519108,"domain_scores_codex":[0.9960399,0.001406062,0.0008676356,0.0001673516,0.001260999,0.00025809],"domain_scores_gemma":[0.9908698,0.002929199,0.0011383,0.0001621833,0.004002506,0.0008979075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009417409,0.0002535551,0.001446428,0.001940417,0.00006032295,0.0003560431,0.0002129415,0.0006092852,0.0002898217,0.00374318,0.6987036,0.2922902],"study_design_scores_gemma":[0.0003505958,0.0001487,0.004759984,0.01520009,0.0001362965,0.0008277316,0.0001887666,0.0007095274,0.0002431366,0.00432297,0.9730674,0.00004483489],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.007517736,0.1857498,0.02338413,0.4150994,0.01372546,0.004609901,0.01364472,0.001897525,0.3343714],"genre_scores_gemma":[0.05737402,0.3272586,0.1945255,0.2566879,0.01275676,0.01260586,0.0377087,0.0006624105,0.1004201],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01468289,"threshold_uncertainty_score":0.04911917,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2926447864","doi":"10.1097/hs9.0000000000000185","title":"CAR‐T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope","year":2019,"lang":"en","type":"review","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Sanofi Genzyme; Therakos; Celgene; Mallinckrodt Pharmaceuticals; Gilead Sciences; Sanofi; AOP Orphan; GlaxoSmithKline; Amgen","keywords":"Medicine; Chimeric antigen receptor; Cytokine release syndrome; Lymphoma; Hematopoietic stem cell transplantation; Cell therapy; Clinical trial; Oncology; Transplantation; Immunotherapy; Adverse effect; Blinatumomab; Immunology; Internal medicine; Stem cell; CD19; Antigen; Immune system; Biology","authors":[{"name":"Georg Hopfinger","is_ca":false},{"name":"Ulrich Jäger","is_ca":false},{"name":"Nina Worel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05290399143292113,"gpt":0.3387629218292847,"spread":0.2858589303963636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009646487,0.0004580445,0.0007584846,0.0008357821,0.0001458553,0.0007922639,0.0004575446,0.0009757585,0.002101239],"category_scores_gemma":[0.0007781201,0.0001284981,0.0005470763,0.0007096505,0.00030396,0.001251798,0.0003676786,0.001501224,0.0009123477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002636103,"about_ca_system_score_gemma":0.0004181939,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002762469,"about_ca_topic_score_gemma":0.0006772778,"domain_scores_codex":[0.9997773,0.00006647305,0.00003652708,0.00002842265,0.00006678141,0.00002464706],"domain_scores_gemma":[0.9995961,0.0002181632,0.00006142728,0.00001249731,0.00007483287,0.00003711402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003227964,0.000118544,0.0002098866,0.008602524,0.0001151602,0.0002415285,0.00006409171,0.0004683675,0.002574817,0.002066852,0.03055033,0.9546651],"study_design_scores_gemma":[0.0002270558,0.001276704,0.001790032,0.005510658,0.0003957308,0.002118212,0.00009336259,0.0003623912,0.001240624,0.003249396,0.9837012,0.0000346627],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000544948,0.9971645,0.0001951957,0.0009317731,0.0003724364,0.000008053875,0.00002456175,0.000009031231,0.0007494072],"genre_scores_gemma":[0.003374195,0.9922864,0.0003705886,0.001788224,0.001018858,0.00002174936,0.00007215863,0.000005498396,0.001062267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002101239,"threshold_uncertainty_score":0.007029355,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949444368","doi":"10.1097/01.hs9.0000561592.51072.9b","title":"S828 A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM‐151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Essential thrombocythemia; Internal medicine; Randomization; Bone marrow; Polycythemia vera; Gastroenterology; Randomized controlled trial; Anemia","authors":[{"name":"Srđan Verstovšek","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Martha Wadleigh","is_ca":false},{"name":"Jodie Palmer","is_ca":false},{"name":"Alessandro Isidori","is_ca":false},{"name":"Peter A.W. te Boekhorst","is_ca":false},{"name":"Michael R. Savona","is_ca":false},{"name":"Jason Gotlib","is_ca":false},{"name":"Robert P. Hasserjian","is_ca":false},{"name":"Olga Pozdnyakova","is_ca":false},{"name":"Olga K. Weinberg","is_ca":false},{"name":"Thorsten Derlin","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Ellen K. Ritchie","is_ca":false},{"name":"Joana Mascarenhas","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Bernt van den Blink","is_ca":false},{"name":"Claire Harrison","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03123546288346078,"gpt":0.3296657506900283,"spread":0.2984302878065675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001570519,0.001745364,0.003008235,0.0005097334,0.0004606329,0.0009571794,0.0009489101,0.001861845,0.006899923],"category_scores_gemma":[0.001225181,0.0009625091,0.001623254,0.0003625296,0.001248426,0.001161371,0.0003565882,0.002581538,0.00119161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006376326,"about_ca_system_score_gemma":0.001389369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005090269,"about_ca_topic_score_gemma":0.001394565,"domain_scores_codex":[0.9994228,0.000290488,0.00003364215,0.0001127722,0.00003488765,0.0001054724],"domain_scores_gemma":[0.9992272,0.0001596535,0.0001399707,0.00008431653,0.00005897368,0.0003299498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9515601,0.02345553,0.0008619227,0.0003025874,0.0003891722,0.00006606379,0.00006832489,0.0004376278,0.009153022,0.0001200182,0.0008467349,0.01273887],"study_design_scores_gemma":[0.8812168,0.1164001,0.001259561,0.000009096157,0.0001052986,0.00003165326,0.00001024217,0.0002162638,0.0003334421,0.00005973936,0.0003450116,0.00001278884],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898736,0.001083058,0.0005717663,0.0004604347,0.0002415999,0.005138536,0.001020487,0.0001310572,0.001479492],"genre_scores_gemma":[0.9848419,0.0008040387,0.00177309,0.00121049,0.0003205176,0.007138764,0.001354693,0.00002558599,0.002530881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006899923,"threshold_uncertainty_score":0.02308255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3005061455","doi":"10.1097/hs9.0000000000000327","title":"Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms","year":2020,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Cancer Council Western Australia; National Health and Medical Research Council; Queen's University; Queen's University Belfast; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Odds ratio; Confidence interval; Internal medicine; Population; Cohort study; Cohort; Essential thrombocythemia; Demography; Pediatrics; Polycythemia vera; Environmental health","authors":[{"name":"Andrew Duncombe","is_ca":false},{"name":"Lesley Anderson","is_ca":false},{"name":"Glen James","is_ca":false},{"name":"Frank de Vocht","is_ca":false},{"name":"Lin Fritschi","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Mike Clarke","is_ca":false},{"name":"Mary Frances McMullin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02583528276933299,"gpt":0.2479246808615806,"spread":0.2220893980922476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002303773,0.0001971408,0.0002499781,0.0006668745,0.0002925057,0.0004761685,0.0002458859,0.0003935538,0.002468521],"category_scores_gemma":[0.001305785,0.0001661376,0.000326721,0.00102593,0.0001775527,0.0001988784,0.0002486347,0.00055917,0.0002200285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002391465,"about_ca_system_score_gemma":0.000212695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004883107,"about_ca_topic_score_gemma":0.005938139,"domain_scores_codex":[0.9997652,0.00006649526,0.00002435419,0.00005526295,0.00004317613,0.00004556457],"domain_scores_gemma":[0.9992608,0.0001235038,0.0003373376,0.00005180478,0.00006435341,0.000162173],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001733224,0.00007466479,0.9959015,0.00003089321,0.000110738,0.0001403099,0.00005050945,0.00003399204,0.0004573254,0.00004392285,0.00008665935,0.002896116],"study_design_scores_gemma":[0.000003020656,0.00005835538,0.9994333,0.000007823135,0.00002916235,0.0001607759,0.00002967036,0.00006460288,0.00003228812,0.00002960388,0.0001493032,0.000002057213],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945619,0.002412585,0.000188627,0.0001783012,0.00002045964,0.00001741432,0.000783599,0.000012287,0.001824913],"genre_scores_gemma":[0.998482,0.0004813383,0.0001959285,0.0000320734,0.00002938469,0.000008321734,0.0002814974,0.000003377733,0.0004859724],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004883107,"threshold_uncertainty_score":0.009709358,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2802748326","doi":"10.1097/hs9.0000000000000044","title":"Clinical Utility of Next‐generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single‐Center Experience","year":2018,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"European Hematology Association; Bristol-Myers Squibb","keywords":"Medicine; Myeloid; Oncology; Internal medicine; Myelofibrosis; DNA sequencing; Bioinformatics; Gene; Biology; Genetics; Bone marrow","authors":[{"name":"Waleed Alduaij","is_ca":true},{"name":"Caroline McNamara","is_ca":true},{"name":"Andre C. Schuh","is_ca":true},{"name":"Andrea Arruda","is_ca":true},{"name":"Mahadeo A. Sukhai","is_ca":true},{"name":"Nisha Kanwar","is_ca":true},{"name":"Mariam Thomas","is_ca":true},{"name":"Jay Y. Spiegel","is_ca":true},{"name":"Theodore A. Kennedy","is_ca":true},{"name":"Tracy Stockley","is_ca":true},{"name":"Hubert Tsui","is_ca":true},{"name":"Rebecca Devlin","is_ca":true},{"name":"Hassan Sibai","is_ca":true},{"name":"Dawn Maze","is_ca":true},{"name":"Aaron D. Schimmer","is_ca":true},{"name":"Karen Yee","is_ca":true},{"name":"Steven M. Chan","is_ca":true},{"name":"Suzanne Kamel‐Reid","is_ca":true},{"name":"Vikas Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1708202741207578,"gpt":0.3693284758710335,"spread":0.1985082017502757,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002911179,0.0003556362,0.0004312252,0.0002272469,0.0004094114,0.0007705442,0.0002568124,0.0004941989,0.002525423],"category_scores_gemma":[0.002887746,0.0001356897,0.0004081581,0.0002473798,0.0002794951,0.0005251767,0.0004132245,0.0007985465,0.001013631],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002754813,"about_ca_system_score_gemma":0.0005071147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004614642,"about_ca_topic_score_gemma":0.001091589,"domain_scores_codex":[0.9992886,0.0003561787,0.00005104128,0.0001422607,0.00009449692,0.00006747783],"domain_scores_gemma":[0.9986284,0.0006546588,0.000130733,0.0001351332,0.0001959283,0.0002551704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002655913,0.00189351,0.1609644,0.0004907392,0.0006103525,0.0053238,0.001265477,0.00391257,0.04866377,0.0007730494,0.01344922,0.7599972],"study_design_scores_gemma":[0.002067418,0.03394613,0.5075617,0.001498597,0.002320409,0.08848887,0.002622027,0.03886754,0.1108596,0.005906213,0.2055509,0.0003105677],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9226653,0.01600864,0.04292406,0.003000902,0.0004774385,0.0006721913,0.001230704,0.0004561636,0.01256466],"genre_scores_gemma":[0.9744343,0.004184844,0.01589482,0.002255556,0.0002128078,0.0001666165,0.001127068,0.0001465738,0.001577394],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002911179,"threshold_uncertainty_score":0.015396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283217918","doi":"10.1097/hs9.0000000000000745","title":"A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Follicular lymphoma; Internal medicine; Refractory (planetary science); Retrospective cohort study; Rituximab; Confidence interval; Cohort; Oncology; Lymphoma; Surgery; Biology","authors":[{"name":"Gilles Salles","is_ca":false},{"name":"Stephen J. Schuster","is_ca":false},{"name":"Luca Fischer","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Piers Patten","is_ca":false},{"name":"Bastian von Tresckow","is_ca":false},{"name":"Sonali M. Smith","is_ca":false},{"name":"Ana Jiménez Ubieto","is_ca":false},{"name":"Keith L. Davis","is_ca":false},{"name":"Saurabh Nagar","is_ca":false},{"name":"Jie Zhang","is_ca":false},{"name":"Vamsi Bollu","is_ca":false},{"name":"Etienne Jousseaume","is_ca":false},{"name":"Roberto Ramos","is_ca":false},{"name":"Yucai Wang","is_ca":false},{"name":"Brian K. Link","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009417120956188822,"gpt":0.2423178814031822,"spread":0.2329007604469934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001484631,0.0002963326,0.0004439311,0.0007699347,0.0005626786,0.0006773967,0.0003501374,0.0003809126,0.001024577],"category_scores_gemma":[0.00264997,0.0003220215,0.0004215158,0.0008648014,0.0002983997,0.0007208621,0.000551765,0.000515909,0.0003047353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004708778,"about_ca_system_score_gemma":0.0004478445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003279973,"about_ca_topic_score_gemma":0.003670949,"domain_scores_codex":[0.9988887,0.0003041554,0.0001451548,0.0003350677,0.0001762275,0.0001506878],"domain_scores_gemma":[0.9971987,0.000377389,0.001280458,0.0004837275,0.0002786638,0.0003810895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004492481,0.00008733795,0.9977315,0.00001063241,0.00006172338,0.00009027084,0.00007590426,0.0000247449,0.0001748978,0.00001804281,0.00011611,0.001159654],"study_design_scores_gemma":[0.0000965404,0.001367416,0.9960048,0.000009462921,0.00008908208,0.0009280411,0.0002506865,0.0002192587,0.0001466318,0.00002560626,0.000852372,0.00001024018],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985317,0.0001740223,0.0001634319,0.00001549389,0.000004580974,0.00004738402,0.0008109809,0.000005064924,0.000247315],"genre_scores_gemma":[0.9983875,0.00006337281,0.0001363386,0.00004034761,0.00001369521,0.00004139413,0.001200507,0.000002898865,0.0001139665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003279973,"threshold_uncertainty_score":0.007851601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3193211635","doi":"10.1097/hs9.0000000000000617","title":"Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial","year":2021,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Cytarabine; Hazard ratio; Clinical endpoint; Myeloid leukemia; Randomized controlled trial; Surgery; Confidence interval","authors":[{"name":"Hartmut Döhner","is_ca":false},{"name":"Argiris Symeonidis","is_ca":false},{"name":"Dries Deeren","is_ca":false},{"name":"Judit Demeter","is_ca":false},{"name":"Miguel Á. Sanz","is_ca":false},{"name":"Αchilles Anagnostopoulos","is_ca":false},{"name":"Jordi Esteve","is_ca":false},{"name":"Walter Fiedler","is_ca":false},{"name":"Kimmo Porkka","is_ca":false},{"name":"Hee‐Je Kim","is_ca":false},{"name":"Je‐Hwan Lee","is_ca":false},{"name":"Kensuke Usuki","is_ca":false},{"name":"Stefano D’Ardìa","is_ca":false},{"name":"Chul Won Jung","is_ca":false},{"name":"Olga Salamero","is_ca":false},{"name":"Heinz‐August Horst","is_ca":false},{"name":"Christian Récher","is_ca":false},{"name":"Philippe Rousselot","is_ca":false},{"name":"Irwindeep Sandhu","is_ca":true},{"name":"Koen Theunissen","is_ca":false},{"name":"Felicitas Thol","is_ca":false},{"name":"Konstanze Döhner","is_ca":false},{"name":"Veronica Teleanu","is_ca":false},{"name":"Daniel J. DeAngelo","is_ca":false},{"name":"Tomoki Naoe","is_ca":false},{"name":"Mikkael A. Sekeres","is_ca":false},{"name":"Valérie Belsack","is_ca":false},{"name":"Miaomiao Ge","is_ca":false},{"name":"Tillmann Taube","is_ca":false},{"name":"Oliver G. Ottmann","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02104062024741899,"gpt":0.311902993568538,"spread":0.290862373321119,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001196189,0.0009488171,0.001824215,0.0002381586,0.0002592089,0.0008077895,0.0005753691,0.001004605,0.003960534],"category_scores_gemma":[0.0009596011,0.0002700507,0.001480919,0.0003283557,0.0006123979,0.0006361757,0.0003082043,0.002630014,0.0006975503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004667041,"about_ca_system_score_gemma":0.0008557739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003254386,"about_ca_topic_score_gemma":0.001123331,"domain_scores_codex":[0.9996939,0.0001743171,0.00001572033,0.00004707084,0.00002653916,0.00004247883],"domain_scores_gemma":[0.9994949,0.0001277535,0.0001370741,0.00004238751,0.00002816299,0.0001698031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9015991,0.01097578,0.001416391,0.001327802,0.001262077,0.0001543921,0.0001097425,0.001079871,0.008337295,0.0003806755,0.002910379,0.07044651],"study_design_scores_gemma":[0.9081109,0.08602339,0.002230761,0.0000550526,0.0002972606,0.0001293659,0.00002356184,0.000668306,0.0004826607,0.0003169657,0.001648497,0.00001326876],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9832339,0.008371958,0.0008260607,0.0009372043,0.0004780569,0.002746202,0.0008170275,0.00017455,0.002415071],"genre_scores_gemma":[0.9801602,0.005741423,0.002460868,0.001874955,0.0004445668,0.004794574,0.001739934,0.00002847351,0.002754905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003960534,"threshold_uncertainty_score":0.01324928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2903296906","doi":"10.1097/hs9.0000000000000159","title":"Maintenance Therapy With Interleukin‐2 for Childhood AML","year":2018,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Assistance publique-Hôpitaux de Paris; Institut National Du Cancer; Fondation ARC pour la Recherche sur le Cancer; CNIB; Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'Adolescent; Association Laurette Fugain","keywords":"Medicine; Cytarabine; Internal medicine; Mitoxantrone; Maintenance therapy; Acute myeloblastic leukemia; Population; Randomized controlled trial; Leukemia; Chemotherapy; Surgery; Oncology","authors":[{"name":"Arnaud Petit","is_ca":false},{"name":"Stéphane Ducassou","is_ca":false},{"name":"Thierry Leblanc","is_ca":false},{"name":"Marlène Pasquet","is_ca":false},{"name":"Alexandra Rousseau","is_ca":false},{"name":"Christine Ragu","is_ca":false},{"name":"Marine Cachanado","is_ca":false},{"name":"Brigitte Nelken","is_ca":false},{"name":"Yves Bertrand","is_ca":false},{"name":"Gérard Michel","is_ca":false},{"name":"Virginie Gandemer","is_ca":false},{"name":"Wendy Cuccuini","is_ca":false},{"name":"Odile Fenneteau","is_ca":false},{"name":"Hélène Lapillonne","is_ca":false},{"name":"Anne Auvrignon","is_ca":false},{"name":"André Baruchel","is_ca":false},{"name":"Guy Leverger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01942172437078197,"gpt":0.2944160902014198,"spread":0.2749943658306378,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005886795,0.0001866907,0.000278285,0.0001964125,0.0001430437,0.0002228139,0.0002425321,0.0001592394,0.007696393],"category_scores_gemma":[0.0008497804,0.00005967028,0.0002831846,0.00015957,0.00009715115,0.0002336958,0.0002670117,0.0005070038,0.0007828779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002269564,"about_ca_system_score_gemma":0.000405471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002756865,"about_ca_topic_score_gemma":0.0005934411,"domain_scores_codex":[0.999702,0.0001248911,0.00001483296,0.00003152609,0.00005226808,0.0000744252],"domain_scores_gemma":[0.9995291,0.0001872277,0.00007507531,0.00005964101,0.00002646801,0.0001225366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.08387084,0.002866436,0.1612168,0.0006415262,0.00217128,0.001541629,0.0001786623,0.001008522,0.06472772,0.001123305,0.01501056,0.6656427],"study_design_scores_gemma":[0.01038385,0.08305956,0.6732265,0.0002686259,0.001903076,0.01379133,0.0001556033,0.00460426,0.03377733,0.001049949,0.1777385,0.00004138516],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9637214,0.01611054,0.001609303,0.0006394284,0.0003747159,0.0002061727,0.0007903904,0.0002172703,0.01633069],"genre_scores_gemma":[0.9941412,0.001023781,0.0007523625,0.0002365607,0.0001275952,0.00009536392,0.0006883958,0.00001190566,0.002922811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007696393,"threshold_uncertainty_score":0.025747,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3157098966","doi":"10.1097/hs9.0000000000000562","title":"Fedratinib Improves Myelofibrosis-related Symptoms and Health-related Quality of Life in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Patient-reported Outcomes from the Phase II JAKARTA2 Trial","year":2021,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Sierra Oncology; Incyte; Gilead Sciences; CTI Biopharma; Celgene; Sanofi; Bristol-Myers Squibb","keywords":"Myelofibrosis; Ruxolitinib; Medicine; Quality of life (healthcare); Internal medicine; Clinical trial; Population; Physical therapy; Bone marrow","authors":[{"name":"Claire Harrison","is_ca":false},{"name":"Nicolaas Schaap","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Éric Jourdan","is_ca":false},{"name":"Richard T. Silver","is_ca":false},{"name":"Harry C. Schouten","is_ca":false},{"name":"Francesco Passamonti","is_ca":false},{"name":"Sonja Zweegman","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Derek Tang","is_ca":false},{"name":"Pranav Abraham","is_ca":false},{"name":"Jennifer Lord‐Bessen","is_ca":false},{"name":"Shelonitda Rose","is_ca":false},{"name":"Shien Guo","is_ca":false},{"name":"Weiqin Liao","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02729231896859579,"gpt":0.2889486548959623,"spread":0.2616563359273665,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001037905,0.0004954842,0.001017144,0.0001897388,0.0002039885,0.0005229745,0.0002525325,0.0005387458,0.001417471],"category_scores_gemma":[0.0006727698,0.000142869,0.001129915,0.000208387,0.0001919923,0.0003117271,0.0001789181,0.001101698,0.00017559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002635874,"about_ca_system_score_gemma":0.0003384862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005134595,"about_ca_topic_score_gemma":0.001671045,"domain_scores_codex":[0.9997943,0.00008926646,0.0000235437,0.00002506333,0.00002892337,0.00003884307],"domain_scores_gemma":[0.9996756,0.00006041888,0.00009779327,0.00002326649,0.00002486837,0.0001179088],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6003469,0.02209034,0.04947812,0.001502503,0.005224728,0.0004436986,0.0002302868,0.003466536,0.02653388,0.0002271888,0.008682993,0.2817727],"study_design_scores_gemma":[0.4202393,0.2889195,0.267432,0.0002396522,0.003632384,0.00134687,0.0001307368,0.005720077,0.004980528,0.000272142,0.007006275,0.00008038696],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921947,0.005125985,0.000101273,0.0003050153,0.00007806822,0.0002483093,0.0006625068,0.00003732443,0.001246914],"genre_scores_gemma":[0.9949535,0.001761907,0.0002973619,0.0004529205,0.0001227023,0.0001713253,0.001661596,0.000003771894,0.0005748699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001417471,"threshold_uncertainty_score":0.005489051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387969051","doi":"10.1097/hs9.0000000000000963","title":"Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Genentech; Italfarmaco; Galecto; Sierra Oncology; CTI Biopharma; Incyte; Jazz Pharmaceuticals; Yuhan; Gilead Sciences; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer; Constellation Pharmaceuticals","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Post-hoc analysis; Internal medicine; Population; Anemia; Gastroenterology; Bone marrow","authors":[{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Aaron T. Gerds","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Miklós Egyed","is_ca":false},{"name":"Uwe Platzbecker","is_ca":false},{"name":"Jiřı́ Mayer","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Árpád Illés","is_ca":false},{"name":"T Woźny","is_ca":false},{"name":"Stephen T. Oh","is_ca":false},{"name":"Donal P. McLornan","is_ca":false},{"name":"Ilya Kirgner","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Claire Harrison","is_ca":false},{"name":"Barbara Klencke","is_ca":false},{"name":"Mei Huang","is_ca":false},{"name":"Jun Kawashima","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03576256372437367,"gpt":0.3265376126777602,"spread":0.2907750489533865,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072772,0.001525439,0.003831155,0.000476105,0.0003488558,0.001384251,0.0006680762,0.0009903196,0.003477074],"category_scores_gemma":[0.005689294,0.0004268537,0.007038996,0.0006272323,0.0005391547,0.0008613987,0.0004773485,0.001748305,0.0003719972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007233042,"about_ca_system_score_gemma":0.001356003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005803691,"about_ca_topic_score_gemma":0.002045768,"domain_scores_codex":[0.9962003,0.002760893,0.0002744475,0.0003104351,0.0001814564,0.0002724622],"domain_scores_gemma":[0.9956763,0.002386565,0.0008827097,0.0003967261,0.0002538865,0.0004037425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9571123,0.001693065,0.003039114,0.001102654,0.01764925,0.0001108715,0.00005664939,0.001064433,0.002282889,0.00009358675,0.001181744,0.01461348],"study_design_scores_gemma":[0.888999,0.06213617,0.01851438,0.0001155107,0.02404489,0.0001679152,0.00006659042,0.001927411,0.001411585,0.0004285755,0.002137277,0.00005058334],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779105,0.01169208,0.00139962,0.000750478,0.000322818,0.003272872,0.002369812,0.0001318608,0.002149909],"genre_scores_gemma":[0.9889992,0.002883426,0.001303381,0.0007934702,0.0002862337,0.002285491,0.002178208,0.00004015878,0.001230361],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0072772,"threshold_uncertainty_score":0.038486,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388738310","doi":"10.1097/01.hs9.0000936164.84357.ed","title":"P09 DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE (D-RD) VERSUS LENALIDOMIDE AND DEXAMETHASONE (RD) ALONE IN TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): UPDATED ANALYSIS OF THE PHASE 3 MAIA STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Lenalidomide; Medicine; Daratumumab; Internal medicine; Multiple myeloma; Clinical endpoint; Dexamethasone; Surgery; Phases of clinical research; Minimal residual disease; Progression-free survival; Oncology; Gastroenterology; Chemotherapy; Randomized controlled trial; Bone marrow","authors":[{"name":"Katja Weisel","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"T. Facon","is_ca":false},{"name":"Torben Plesner","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Supratik Basu","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Cyrille Hulin","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Michael O’Dwyer","is_ca":false},{"name":"Aurore Perrot","is_ca":false},{"name":"Christopher P. Venner","is_ca":true},{"name":"Noopur Raje","is_ca":false},{"name":"Mourad Tiab","is_ca":false},{"name":"Margaret Macro","is_ca":false},{"name":"Laurent Frenzel","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Huiling Pei","is_ca":false},{"name":"Maria Krevvata","is_ca":false},{"name":"Robin Carson","is_ca":false},{"name":"F. Borgsten","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02799922324280263,"gpt":0.3080481877675247,"spread":0.2800489645247221,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003307183,0.0006997728,0.001883915,0.0003348639,0.0002889627,0.00101272,0.0006881547,0.0004833757,0.001452253],"category_scores_gemma":[0.001614373,0.0003725205,0.002669725,0.000438017,0.0004291017,0.0006501011,0.0004727909,0.002073653,0.0002346738],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007468021,"about_ca_system_score_gemma":0.0009399985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005119924,"about_ca_topic_score_gemma":0.001659999,"domain_scores_codex":[0.9990828,0.0005338494,0.00007341356,0.0001324382,0.00008603387,0.00009150662],"domain_scores_gemma":[0.9984005,0.0004835305,0.0005378238,0.0001346193,0.00006635612,0.000377108],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8547403,0.008501855,0.05385855,0.0005325411,0.00601447,0.0001044252,0.000144813,0.001991461,0.008755135,0.0001611988,0.001609572,0.0635857],"study_design_scores_gemma":[0.3318766,0.421165,0.2219378,0.0001527235,0.01072224,0.000488846,0.0001356891,0.004140762,0.003833962,0.000540457,0.00492232,0.0000836058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946797,0.003405114,0.0002391808,0.0001958611,0.00006672252,0.0002387701,0.0006474137,0.00001478566,0.0005123224],"genre_scores_gemma":[0.9966209,0.0008794711,0.0004806225,0.0002905402,0.0001021384,0.0002623087,0.001049322,0.000005926239,0.0003086211],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003307183,"threshold_uncertainty_score":0.01749027,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399045499","doi":"10.1002/hem3.74","title":"First‐line ibrutinib treatment in patients with chronic lymphocytic leukemia is associated with overall survival rates similar to those of an age‐matched general population: A pooled post hoc analysis","year":2024,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Pharmacyclics","keywords":"Ibrutinib; Post-hoc analysis; Chronic lymphocytic leukemia; Medicine; Oncology; Internal medicine; Post hoc; Pooled analysis; Survival analysis; Population; Leukemia; Meta-analysis","authors":[{"name":"Paolo Ghia","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"John N. Allan","is_ca":false},{"name":"Jacqueline C. Barrientos","is_ca":false},{"name":"Paul M. Barr","is_ca":false},{"name":"Chunxue Shi","is_ca":false},{"name":"Anita Szoke","is_ca":false},{"name":"Christopher Abbazio","is_ca":false},{"name":"Gabriel Krigsfeld","is_ca":false},{"name":"Jan A. Burger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01802651987704014,"gpt":0.2991594278701664,"spread":0.2811329079931262,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007270032,0.001312879,0.003939187,0.001112352,0.0002230107,0.001187602,0.0006328048,0.000908076,0.00355154],"category_scores_gemma":[0.005298099,0.0004060144,0.01161969,0.001014271,0.0002823257,0.001007235,0.0006116801,0.00110941,0.0003244816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005338226,"about_ca_system_score_gemma":0.0004779931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009982274,"about_ca_topic_score_gemma":0.001893644,"domain_scores_codex":[0.9964448,0.001826901,0.0003139933,0.0007805222,0.0003674004,0.0002664407],"domain_scores_gemma":[0.9954834,0.002344511,0.001006265,0.0006013916,0.0002919343,0.0002726237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"observational","study_design_scores_codex":[0.3456205,0.0007078554,0.2379078,0.004679603,0.3491628,0.0005151771,0.0001663719,0.002470232,0.003226122,0.00020061,0.00546098,0.04988186],"study_design_scores_gemma":[0.02282127,0.03814628,0.6384579,0.0004718874,0.2800822,0.0006561599,0.0003151798,0.007496015,0.001523627,0.00049096,0.009374551,0.0001640106],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9182631,0.06720386,0.003345353,0.0003497246,0.0008476923,0.0004646468,0.005763534,0.0001824878,0.003579612],"genre_scores_gemma":[0.9917504,0.003404369,0.0005343511,0.0002839192,0.0003693151,0.0002395925,0.002442341,0.00003481285,0.0009408275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007270032,"threshold_uncertainty_score":0.0384481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386024076","doi":"10.1097/01.hs9.0000967492.06443.0a","title":"S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Obinutuzumab; Venetoclax; Medicine; Chronic lymphocytic leukemia; Internal medicine; Tolerability; Chlorambucil; Bendamustine; Oncology; Hazard ratio; Interquartile range; Clinical endpoint; Leukemia; Gastroenterology; Randomized controlled trial; Cyclophosphamide; Chemotherapy; Adverse effect; Confidence interval","authors":[{"name":"Othman Al‐Sawaf","is_ca":false},{"name":"Sandra Robrecht","is_ca":false},{"name":"Can Zhang","is_ca":false},{"name":"Stefano Olivieri","is_ca":false},{"name":"Yi Meng Chang","is_ca":true},{"name":"Anna‐Maria Fink","is_ca":false},{"name":"Eugen Tausch","is_ca":false},{"name":"Christof Schneider","is_ca":false},{"name":"Matthias Ritgen","is_ca":false},{"name":"Karl‐Anton Kreuzer","is_ca":false},{"name":"Liliya Sivcheva","is_ca":false},{"name":"Carsten Utoft Niemann","is_ca":false},{"name":"Anthony P. Schwarer","is_ca":false},{"name":"Javier Loscertales","is_ca":false},{"name":"Robert Weinkove","is_ca":false},{"name":"Dirk Strumberg","is_ca":false},{"name":"Allanah Kilfoyle","is_ca":false},{"name":"Eva Diana Runkel","is_ca":true},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Stephan Stilgenbauer","is_ca":false},{"name":"Yanwen Jiang","is_ca":false},{"name":"Michael Hallek","is_ca":false},{"name":"Kirsten Fischer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02367475763571688,"gpt":0.3104929278816977,"spread":0.2868181702459809,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005346392,0.00072171,0.001936646,0.000428357,0.0003681096,0.001370179,0.0007407928,0.001987977,0.006415844],"category_scores_gemma":[0.004796871,0.0003145573,0.00323794,0.0005785443,0.000478081,0.0008010719,0.0005706202,0.001924991,0.001164994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008596879,"about_ca_system_score_gemma":0.001321425,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009221486,"about_ca_topic_score_gemma":0.001845791,"domain_scores_codex":[0.9973303,0.00193596,0.0001648971,0.0001702636,0.0002204018,0.000178111],"domain_scores_gemma":[0.9961628,0.001108042,0.00114657,0.000294,0.0004112842,0.0008773474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9171126,0.004326583,0.00607045,0.001248705,0.003538109,0.00006921249,0.00007387288,0.0005989562,0.002660897,0.0002085494,0.006837138,0.0572549],"study_design_scores_gemma":[0.8571014,0.1022014,0.02543477,0.0003290409,0.003831429,0.0001521125,0.00005260795,0.0005703716,0.0007613006,0.0002957836,0.009227969,0.00004185097],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9364039,0.03410544,0.001335015,0.003311514,0.001004734,0.005048232,0.01223372,0.0002324973,0.00632482],"genre_scores_gemma":[0.9541492,0.009549378,0.002518298,0.004240468,0.001322491,0.005030543,0.01621024,0.00009022001,0.00688909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006415844,"threshold_uncertainty_score":0.02827471,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2947040488","doi":"10.1097/hs9.0000000000000250","title":"A Simple RNA Target Capture NGS Strategy for Fusion Genes Assessment in the Diagnostics of Pediatric B‐cell Acute Lymphoblastic Leukemia","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Canadian Thoracic Society","keywords":"Fusion gene; Computational biology; Gold standard (test); Gene; Fusion transcript; Fluorescence in situ hybridization; Molecular diagnostics; Biology; Bioinformatics; Medicine; Genetics; Internal medicine","authors":[{"name":"Andrea Grioni","is_ca":false},{"name":"Grazia Fazio","is_ca":false},{"name":"Silvia Rigamonti","is_ca":false},{"name":"Vojtěch Bystrý","is_ca":false},{"name":"Giulia Daniele","is_ca":false},{"name":"Zuzana Dostálová","is_ca":false},{"name":"Manuel Quadri","is_ca":false},{"name":"Claudia Saitta","is_ca":false},{"name":"Daniela Silvestri","is_ca":false},{"name":"Simona Songia","is_ca":false},{"name":"Clelia Tiziana Storlazzi","is_ca":false},{"name":"Andrea Biondi","is_ca":false},{"name":"Nikos Darzentas","is_ca":false},{"name":"Giovanni Cazzaniga","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01576470586151458,"gpt":0.2963564559634752,"spread":0.2805917501019606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009283021,0.0006060665,0.0002336684,0.0007992108,0.0002737579,0.0004899143,0.0003126468,0.000759734,0.002210909],"category_scores_gemma":[0.0007275011,0.0002331554,0.0003042499,0.0003796089,0.0004716797,0.0002584959,0.0005156341,0.0005076189,0.0008583905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003081003,"about_ca_system_score_gemma":0.0005817932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008342897,"about_ca_topic_score_gemma":0.003536471,"domain_scores_codex":[0.9990786,0.0001862211,0.00005272682,0.0002365607,0.0003654233,0.00008045817],"domain_scores_gemma":[0.999774,0.00009479417,0.00003266755,0.00003172695,0.00004683661,0.00001992546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001418009,0.00006361085,0.005466962,0.0001883281,0.00005157208,0.0003383161,0.00009069431,0.0004977047,0.926262,0.0006679486,0.0009033427,0.0653279],"study_design_scores_gemma":[0.000056737,0.000611132,0.02974654,0.00005821313,0.0001740811,0.00305603,0.0001006455,0.01005062,0.9323145,0.000816257,0.02297343,0.00004183277],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"methods","genre_scores_codex":[0.7112371,0.008601214,0.2530901,0.0009094764,0.0004521158,0.001269856,0.003070122,0.001260778,0.02010929],"genre_scores_gemma":[0.8314735,0.002682676,0.1499677,0.001009536,0.0001276626,0.0006932603,0.002309774,0.0001103434,0.01162553],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.002210909,"threshold_uncertainty_score":0.007396221,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385666327","doi":"10.1097/01.hs9.0000967372.19440.62","title":"S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Blinatumomab; Internal medicine; Minimal residual disease; Oncology; Rituximab; Induction chemotherapy; Chemotherapy; Acute lymphocytic leukemia; Chemotherapy regimen; Lymphoblastic Leukemia; Leukemia; Lymphoma","authors":[{"name":"Mark R. Litzow","is_ca":false},{"name":"Zhuoxin Sun","is_ca":false},{"name":"Ryan J. Mattison","is_ca":false},{"name":"Elisabeth Paietta","is_ca":false},{"name":"Charles G. Mullighan","is_ca":false},{"name":"Kathryn G. Roberts","is_ca":false},{"name":"Yanming Zhang","is_ca":false},{"name":"Janis Racevskis","is_ca":false},{"name":"Cheryl L. Willman","is_ca":false},{"name":"Matthew J. Wieduwilt","is_ca":false},{"name":"Michaela Liedtke","is_ca":false},{"name":"Julie Bergeron","is_ca":true},{"name":"Hillard M. Lazarus","is_ca":false},{"name":"Dan Arber","is_ca":false},{"name":"Brent L. Wood","is_ca":false},{"name":"Jacob M. Rowe","is_ca":false},{"name":"Keith W. Pratz","is_ca":false},{"name":"Shira Dinner","is_ca":false},{"name":"Noelle V. Frey","is_ca":false},{"name":"Steve Gore","is_ca":false},{"name":"Bhavana Bhatnagar","is_ca":false},{"name":"Ehab Atallah","is_ca":false},{"name":"Geoffrey L. Uy","is_ca":false},{"name":"Deepa Jeyakumar","is_ca":false},{"name":"Tara L. Lin","is_ca":false},{"name":"Shejal Patel","is_ca":false},{"name":"Michelle A. Elliott","is_ca":false},{"name":"Anjali S. Advani","is_ca":false},{"name":"Daniel J. DeAngelo","is_ca":false},{"name":"Dimitrios Tzachanis","is_ca":false},{"name":"Pankit Vachhani","is_ca":false},{"name":"Rupali Bhave","is_ca":false},{"name":"Richard F. Little","is_ca":false},{"name":"Harry P. Erba","is_ca":false},{"name":"Richard M. Stone","is_ca":false},{"name":"Selina M. Luger","is_ca":false},{"name":"Martin S. Tallman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01744830779822663,"gpt":0.2722985419114596,"spread":0.254850234113233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000525539,0.0004313341,0.001185129,0.000218032,0.0001370731,0.0005476145,0.0003608204,0.0006404848,0.007086363],"category_scores_gemma":[0.0005680359,0.0001442186,0.001002251,0.00031975,0.0002074503,0.0003878154,0.0002392086,0.0008452592,0.0007701797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003924129,"about_ca_system_score_gemma":0.0005422594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006191721,"about_ca_topic_score_gemma":0.001775081,"domain_scores_codex":[0.9998441,0.00006374582,0.00001775515,0.00002053483,0.00002094286,0.00003292476],"domain_scores_gemma":[0.9997361,0.00005460945,0.0000751127,0.00001886707,0.00001561321,0.00009973124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6499733,0.008477923,0.02607103,0.001517613,0.002100201,0.0002658378,0.0001737018,0.001779793,0.02878254,0.0002343615,0.004517182,0.2761065],"study_design_scores_gemma":[0.2515499,0.4612786,0.2434428,0.0005441529,0.006030866,0.00125674,0.0002451787,0.003565117,0.01768,0.0004592999,0.01386318,0.00008420184],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940804,0.003360674,0.0001006527,0.0003297564,0.0001059491,0.0001954693,0.0005117249,0.00004976484,0.001265677],"genre_scores_gemma":[0.9955729,0.001276625,0.0002154781,0.0003742984,0.00010627,0.0001194275,0.001115606,0.00001054768,0.001208743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007086363,"threshold_uncertainty_score":0.02370626,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4378078281","doi":"10.1097/hs9.0000000000000886","title":"Bleeding and Thrombosis in Patients With Cirrhosis: What’s New?","year":2023,"lang":"en","type":"editorial","venue":"HemaSphere","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cirrhosis; Thrombosis; Medicine; Internal medicine; Cardiology","authors":[{"name":"Ton Lisman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009926677538678964,"gpt":0.2461621774299515,"spread":0.2362354998912725,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001404295,0.0005622974,0.001744871,0.002249746,0.0005513282,0.002607419,0.00100469,0.003552818,0.003915037],"category_scores_gemma":[0.006890819,0.0003301213,0.0008005286,0.003411028,0.001236586,0.004254375,0.0006073458,0.004078144,0.0007418115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007434697,"about_ca_system_score_gemma":0.001229378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005025459,"about_ca_topic_score_gemma":0.005894541,"domain_scores_codex":[0.99891,0.0002729223,0.0002136445,0.0001432054,0.0003288056,0.0001315257],"domain_scores_gemma":[0.9938061,0.002616125,0.001460177,0.0001526836,0.001187658,0.0007772418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000835096,0.0002812817,0.1584835,0.009112948,0.0005236718,0.003669621,0.0007556697,0.0002780363,0.0001938341,0.002434999,0.07057053,0.7528609],"study_design_scores_gemma":[0.0003353231,0.001007637,0.5700203,0.05898941,0.002167909,0.06271025,0.007241827,0.001670299,0.0002595247,0.01872535,0.2763828,0.0004893728],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.01291674,0.9056202,0.0004045576,0.07298485,0.003690614,0.00003032099,0.0003704055,0.00004117159,0.003941098],"genre_scores_gemma":[0.08320139,0.8704274,0.001201216,0.01582975,0.02811928,0.00005661418,0.0005260032,0.00001561677,0.000622707],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.005025459,"threshold_uncertainty_score":0.01309711,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387899802","doi":"10.1097/hs9.0000000000000966","title":"Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; University of Toronto","funders":"Sierra Oncology; MorphoSys; Cancer Research UK; Galecto; Incyte; Gilead Sciences; CTI Biopharma; Division of Materials Research; Celgene; Pfizer","keywords":"Myelofibrosis; Medicine; Quality of life (healthcare); Anemia; Ruxolitinib; Clinical endpoint; Danazol; Internal medicine; Physical therapy; Myeloproliferative neoplasm; Janus kinase 2; Clinical trial; Bone marrow","authors":[{"name":"Ruben A. Mesa","is_ca":false},{"name":"Claire Harrison","is_ca":false},{"name":"Jeanne Palmer","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Donal P. McLornan","is_ca":false},{"name":"Mary Frances McMullin","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Lynda Foltz","is_ca":true},{"name":"Uwe Platzbecker","is_ca":false},{"name":"María Laura Fox","is_ca":false},{"name":"Adam J. Mead","is_ca":false},{"name":"David M. Ross","is_ca":false},{"name":"Stephen T. Oh","is_ca":false},{"name":"Andrew C. Perkins","is_ca":false},{"name":"Michael F. Leahy","is_ca":false},{"name":"Jun Kawashima","is_ca":false},{"name":"Sunhee Ro","is_ca":false},{"name":"Rafe Donahue","is_ca":false},{"name":"Boris Gorsh","is_ca":false},{"name":"Samineh Deheshi","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02757746517641687,"gpt":0.2802369706173891,"spread":0.2526595054409723,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003323894,0.0004675551,0.0008362756,0.0004671766,0.0003821886,0.0008453646,0.0003952715,0.0005937022,0.001214694],"category_scores_gemma":[0.005194456,0.0001900362,0.00139983,0.001072075,0.0002721162,0.00077028,0.0008072655,0.0007795458,0.0002385292],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004988553,"about_ca_system_score_gemma":0.0005494235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001416577,"about_ca_topic_score_gemma":0.002457586,"domain_scores_codex":[0.9988235,0.0005762281,0.0001686718,0.0001361153,0.0002089284,0.0000864449],"domain_scores_gemma":[0.9954615,0.001056288,0.001926601,0.0002496797,0.0006002272,0.00070567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08999447,0.004761276,0.8408722,0.0008335493,0.004482666,0.0001564285,0.0003955686,0.001195989,0.001239702,0.0002295071,0.003830155,0.0520085],"study_design_scores_gemma":[0.008095856,0.01116342,0.9758551,0.00010569,0.001295326,0.0001793214,0.0002007598,0.0007039724,0.0001589162,0.000163956,0.002031509,0.00004621576],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915069,0.002610325,0.0001175215,0.0002878063,0.00002991797,0.0001825034,0.003771843,0.00001015366,0.001483012],"genre_scores_gemma":[0.9914369,0.0008809552,0.0003031346,0.0003309722,0.00009208568,0.0002989329,0.006308401,0.000005266698,0.0003433521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003323894,"threshold_uncertainty_score":0.01757866,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3005070954","doi":"10.1097/hs9.0000000000000319","title":"The Pediatric Acute Leukemia Fusion Oncogene ETO2‐GLIS2 Increases Self‐Renewal and Alters Differentiation in a Human Induced Pluripotent Stem Cells‐Derived Model","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institut National Du Cancer; Fondation pour la Recherche Médicale; Cancéropôle Ile de France; Agence Nationale de la Recherche; CNIB","keywords":"Induced pluripotent stem cell; Stem cell; Cell biology; Oncogene; Cancer research; Leukemia; Biology; Embryonic stem cell; Neuroscience; Immunology; Apoptosis; Cell cycle; Genetics; Gene","authors":[{"name":"Salvatore Nicola Bertuccio","is_ca":false},{"name":"Fabien Boudia","is_ca":false},{"name":"Marie Cambot","is_ca":false},{"name":"Cécile K. Lopez","is_ca":false},{"name":"Larissa Lordier","is_ca":false},{"name":"Alessandro Donada","is_ca":false},{"name":"Elie Robert","is_ca":false},{"name":"Cécile Thirant","is_ca":false},{"name":"Zakia Aid","is_ca":false},{"name":"Salvatore Serravalle","is_ca":false},{"name":"Annalisa Astolfi","is_ca":false},{"name":"Valentina Indio","is_ca":false},{"name":"Franco Locatelli","is_ca":false},{"name":"Andrea Pession","is_ca":false},{"name":"William Vainchenker","is_ca":false},{"name":"Riccardo Masetti","is_ca":false},{"name":"Hana Raslová","is_ca":false},{"name":"Thomas Mercher","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007684411805674912,"gpt":0.2162401684229523,"spread":0.2085557566172773,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001919974,0.0002098861,0.0001580002,0.0002747744,0.0001662094,0.0003022829,0.000236118,0.0002589681,0.00266283],"category_scores_gemma":[0.00008527767,0.0001258508,0.0002098619,0.0002655924,0.0001851237,0.0001841856,0.0001700557,0.0005855731,0.0003622332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004072927,"about_ca_system_score_gemma":0.0002976694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001556253,"about_ca_topic_score_gemma":0.002957302,"domain_scores_codex":[0.9998337,0.00002123185,0.00002128387,0.00003127043,0.00006091342,0.00003148439],"domain_scores_gemma":[0.9999216,0.00002058768,0.00002128488,0.000009862058,0.000005561662,0.0000210566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005466542,0.0001459377,0.0006717194,0.00004716768,0.0000187433,0.0001703349,0.00004390151,0.0006456093,0.9926495,0.001106571,0.0007044512,0.003249343],"study_design_scores_gemma":[0.00008511101,0.0003480919,0.004632399,0.000007142341,0.00003194937,0.0002892338,0.00005645843,0.002467405,0.9839298,0.0001145948,0.008032201,0.0000056146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890624,0.0006194717,0.003153607,0.0002103325,0.0000463314,0.0000649445,0.003290046,0.0001337744,0.003419179],"genre_scores_gemma":[0.988675,0.0008379072,0.002130026,0.00007136903,0.000006505141,0.00006722139,0.002660017,0.0000302041,0.005521658],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00266283,"threshold_uncertainty_score":0.008908093,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283326517","doi":"10.1097/01.hs9.0000843644.02496.66","title":"S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Oncology; Multiple myeloma; Adverse effect; Phases of clinical research; Refractory (planetary science); Clinical trial; Bortezomib","authors":[{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Anita D’Souza","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"N. W. van de Donk","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Aparna Krishnan","is_ca":false},{"name":"Thomas G. Martin","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Daniel Morillo","is_ca":false},{"name":"David D. Hurd","is_ca":false},{"name":"Laura Rosiñol","is_ca":false},{"name":"Ralph Wäsch","is_ca":false},{"name":"Deeksha Vishwamitra","is_ca":false},{"name":"Shu-Chen Lin","is_ca":false},{"name":"Thomas J. Prior","is_ca":false},{"name":"Lien Vandenberk","is_ca":false},{"name":"M.-A. D. Smit","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Bhagirathbhai Dholaria","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03588206454185491,"gpt":0.3080620892896637,"spread":0.2721800247478088,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002742247,0.0006679558,0.00113317,0.0006153722,0.0002068705,0.001045103,0.0007749618,0.0008093482,0.004283926],"category_scores_gemma":[0.001193704,0.000246385,0.001139897,0.0006407019,0.000231561,0.0005968997,0.0003268587,0.001105095,0.001103552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007299456,"about_ca_system_score_gemma":0.001474863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00092195,"about_ca_topic_score_gemma":0.002036135,"domain_scores_codex":[0.99937,0.0002433547,0.00006554615,0.00004716657,0.0001979173,0.00007606859],"domain_scores_gemma":[0.999241,0.0001351148,0.0002937392,0.00003227175,0.0001582651,0.0001395496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.07514418,0.005761216,0.01212287,0.005825459,0.003686935,0.0006439128,0.0002058519,0.002189639,0.05102475,0.0006255688,0.05355142,0.7892182],"study_design_scores_gemma":[0.1722084,0.1835825,0.1227201,0.002876655,0.01094941,0.006890804,0.0001772756,0.004311267,0.05191645,0.0008235521,0.4433688,0.0001747649],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6397173,0.2951602,0.003910506,0.007403472,0.001823251,0.004330094,0.01836904,0.000756966,0.02852917],"genre_scores_gemma":[0.7840316,0.1352261,0.01197325,0.01126854,0.002088899,0.002565295,0.04280093,0.00023347,0.00981191],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004283926,"threshold_uncertainty_score":0.01450258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386024134","doi":"10.1097/01.hs9.0000967716.49281.3f","title":"S201: FINAL 7-YEAR FOLLOW UP AND RETREATMENT SUBSTUDY ANALYSIS OF MURANO: VENETOCLAX-RITUXIMAB (VENR)-TREATED PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Bendamustine; Hazard ratio; Rituximab; Gastroenterology; Confidence interval; Neutropenia; Minimal residual disease; Chronic lymphocytic leukemia; Surgery; Oncology; Leukemia; Chemotherapy; Lymphoma","authors":[{"name":"Arnon P. Kater","is_ca":false},{"name":"Rosemary Harrup","is_ca":false},{"name":"Thomas J. Kipps","is_ca":false},{"name":"Barbara Eichhorst","is_ca":false},{"name":"Carolyn Owen","is_ca":true},{"name":"Sarit Assouline","is_ca":true},{"name":"Nicole Lamanna","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"Javier de la Serna","is_ca":false},{"name":"Ulrich Jaeger","is_ca":false},{"name":"Guillaume Cartron","is_ca":false},{"name":"Marco Montillo","is_ca":false},{"name":"Clemens Mellink","is_ca":false},{"name":"Brenda Chyla","is_ca":false},{"name":"Maria Thadani‐Mulero","is_ca":false},{"name":"Marcus Lefebure","is_ca":false},{"name":"Yanwen Jiang","is_ca":true},{"name":"Rosemary Millen","is_ca":false},{"name":"Michelle Boyer","is_ca":false},{"name":"John F. Seymour","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02021042823609262,"gpt":0.2684018237487544,"spread":0.2481913955126618,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002905279,0.0006442902,0.001877225,0.0004321066,0.000495002,0.001016229,0.0007749655,0.000948488,0.001973331],"category_scores_gemma":[0.001763977,0.0004044354,0.002404877,0.0008262328,0.0004656188,0.0005848394,0.0006649994,0.001518246,0.0006191977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001091208,"about_ca_system_score_gemma":0.001082702,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002133939,"about_ca_topic_score_gemma":0.006923514,"domain_scores_codex":[0.9987914,0.0005686966,0.00009725496,0.0002168536,0.0001527755,0.0001730044],"domain_scores_gemma":[0.9983124,0.000290716,0.0004780191,0.0002733567,0.0002258319,0.0004196603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5158298,0.007465844,0.3310331,0.002213868,0.01756619,0.0008255424,0.0008776567,0.00201987,0.02424172,0.000432102,0.02040784,0.0770865],"study_design_scores_gemma":[0.1070117,0.07972778,0.7732438,0.0002498504,0.01386022,0.001322814,0.000312558,0.001217536,0.003804513,0.0004003477,0.01876032,0.00008857761],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98344,0.002419289,0.0003246306,0.0002898131,0.0000786559,0.0007186548,0.01082095,0.00005171931,0.00185635],"genre_scores_gemma":[0.9545439,0.0008460092,0.0008201906,0.0009988965,0.00018168,0.00122037,0.0398044,0.00003481363,0.001549712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002905279,"threshold_uncertainty_score":0.01536477,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283312353","doi":"10.1097/01.hs9.0000843628.63947.e4","title":"S184: EVALUATING TECLISTAMAB IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA FOLLOWING EXPOSURE TO OTHER B-CELL MATURATION ANTIGEN (BCMA)-TARGETED AGENTS","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Institute of Cancer Research","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Cytokine release syndrome; Chimeric antigen receptor; Cohort; Oncology; Antigen; Gastroenterology; Immunology; Cancer; Immunotherapy","authors":[{"name":"C. Touzeau","is_ca":false},{"name":"A. Krishnan","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"A. Perrot","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Salomon Manier","is_ca":false},{"name":"M. Cavo","is_ca":false},{"name":"Carmen Martínez‐Chamorro","is_ca":false},{"name":"A. Nooka","is_ca":false},{"name":"T. Martin","is_ca":false},{"name":"L. Karlin","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Britta Besemer","is_ca":false},{"name":"Lixia Pei","is_ca":false},{"name":"R. Verona","is_ca":false},{"name":"Sarah Girgis","is_ca":false},{"name":"C. Uhlar","is_ca":false},{"name":"Rachel Kobos","is_ca":false},{"name":"A. Garfall","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02526965690813318,"gpt":0.2987480830311138,"spread":0.2734784261229806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009796255,0.0004758523,0.001025273,0.0002984574,0.0002578979,0.0004787804,0.0002980835,0.0004408378,0.002069284],"category_scores_gemma":[0.0007949213,0.0001862284,0.001116102,0.000364121,0.00019535,0.0003189906,0.0002267904,0.0005338361,0.0004126413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008131186,"about_ca_system_score_gemma":0.001121382,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007444602,"about_ca_topic_score_gemma":0.001858533,"domain_scores_codex":[0.9997256,0.0001167412,0.00002752784,0.00004972256,0.0000402674,0.00004012434],"domain_scores_gemma":[0.9995756,0.00007652039,0.0001477322,0.00002156762,0.00004347122,0.0001350951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.506559,0.009209551,0.2012675,0.001631483,0.003658105,0.001573151,0.000398528,0.004566552,0.0590686,0.000181184,0.002933797,0.2089526],"study_design_scores_gemma":[0.08369102,0.5670742,0.3145383,0.0001503311,0.003551271,0.002358427,0.0001784706,0.003906579,0.01368751,0.0001758773,0.01064437,0.00004349384],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970092,0.001032556,0.0001448163,0.00009823347,0.00001904188,0.0003899155,0.0004744024,0.00002130734,0.0008105306],"genre_scores_gemma":[0.9973636,0.0004984549,0.00033234,0.0001769644,0.00005183544,0.000226708,0.0008741764,0.000004701093,0.0004711901],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002069284,"threshold_uncertainty_score":0.006922483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2951457160","doi":"10.1097/01.hs9.0000559376.17429.23","title":"PF291 A PHASE 1B/2 CLINICAL STUDY OF TARGETED IDH1 INHIBITION WITH IVOSIDENIB, IN COMBINATION WITH THE BCL‐2 INHIBITOR VENETOCLAX, FOR PATIENTS WITH IDH1‐MUTATED (MIDH1) MYELOID MALIGNANCIES","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Ven; IDH1; Medicine; Tolerability; Internal medicine; Oncology; Refractory (planetary science); Myeloid; Myeloid leukemia; Gastroenterology; Leukemia; Adverse effect; Chronic lymphocytic leukemia; Chemistry; Biology; Mutation","authors":[{"name":"Courtney D. DiNardo","is_ca":false},{"name":"Kazuto Takahashi","is_ca":false},{"name":"Tapan M. Kadia","is_ca":false},{"name":"Sanam Loghavi","is_ca":false},{"name":"Kiran Naqvi","is_ca":false},{"name":"P. Bose","is_ca":false},{"name":"Naval Daver","is_ca":false},{"name":"George D. Tippett","is_ca":false},{"name":"Gautam Borthakur","is_ca":false},{"name":"Jörge E. Cortes","is_ca":false},{"name":"Steven M. Chan","is_ca":true},{"name":"Lynn Quek","is_ca":false},{"name":"Paresh Vyas","is_ca":false},{"name":"H. Kantarjian","is_ca":false},{"name":"Marina Konopleva","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01650303000590497,"gpt":0.3079110771014915,"spread":0.2914080470955865,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001162511,0.001274765,0.0009637066,0.0003149405,0.0003679726,0.0007572612,0.0006568318,0.001188975,0.006579893],"category_scores_gemma":[0.0006674324,0.0004350432,0.0006848397,0.0002544973,0.0006730427,0.0006761894,0.0002939843,0.002692231,0.001283328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009001315,"about_ca_system_score_gemma":0.001899998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009327142,"about_ca_topic_score_gemma":0.002828615,"domain_scores_codex":[0.9996825,0.0001561679,0.00001153162,0.00005398264,0.00003426466,0.00006140953],"domain_scores_gemma":[0.9996147,0.00006042223,0.00006112619,0.00002281741,0.00003123908,0.0002096814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5491193,0.1121361,0.006138195,0.00149976,0.0008970769,0.0007584261,0.000457813,0.005767937,0.1358045,0.001120568,0.02809261,0.1582078],"study_design_scores_gemma":[0.5692559,0.3985191,0.009541267,0.0000734343,0.0002143779,0.00080543,0.00005518153,0.002516213,0.008415824,0.0005923302,0.009970111,0.00004086361],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733648,0.00422097,0.001689416,0.001559281,0.0002221953,0.006482721,0.005576728,0.0003542249,0.006529551],"genre_scores_gemma":[0.9751648,0.002150584,0.00361396,0.001484379,0.0001447172,0.003480522,0.00731452,0.00006584778,0.006580626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006579893,"threshold_uncertainty_score":0.022012,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385667297","doi":"10.1097/01.hs9.0000968132.86513.06","title":"S305: PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; Western University","funders":"","keywords":"Medicine; ADAMTS13; Thrombotic thrombocytopenic purpura; Placebo; Internal medicine; Gastroenterology; Clinical endpoint; Adverse effect; Thrombotic microangiopathy; Randomized controlled trial; Platelet; Disease; Pathology","authors":[{"name":"Marie Scully","is_ca":false},{"name":"Jovanna Baptista","is_ca":false},{"name":"Indranil Bhattacharya","is_ca":false},{"name":"Spero R. Cataland","is_ca":false},{"name":"Paul Coppo","is_ca":false},{"name":"Loredana Cuccia","is_ca":false},{"name":"Tina Dutt","is_ca":false},{"name":"Shih‐Han S. Huang","is_ca":true},{"name":"Cristina Pascual","is_ca":false},{"name":"María Eva Mingot‐Castellano","is_ca":false},{"name":"Aric Parnes","is_ca":false},{"name":"Katerina Pavenski","is_ca":true},{"name":"Kavitha Rajavel","is_ca":false},{"name":"Isidro Jarque","is_ca":false},{"name":"Linda T. Wang","is_ca":false},{"name":"Miguel Fernández Zarzoso","is_ca":false},{"name":"Andy Z. X. Zhu","is_ca":false},{"name":"Björn Mellgård","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02440366224807412,"gpt":0.2909944128602566,"spread":0.2665907506121825,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00215453,0.001971614,0.002612499,0.0004130432,0.0004683198,0.0008525435,0.0008559125,0.002024208,0.009642081],"category_scores_gemma":[0.001481343,0.0007941774,0.001508579,0.0004066438,0.0008502168,0.0009765695,0.0003396776,0.00241695,0.001522266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006169283,"about_ca_system_score_gemma":0.002176397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007061152,"about_ca_topic_score_gemma":0.002229684,"domain_scores_codex":[0.9993519,0.0003527297,0.00004073313,0.0001002219,0.00004986407,0.0001044793],"domain_scores_gemma":[0.999278,0.000158651,0.0001820054,0.00005871684,0.00006604294,0.0002566344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9671157,0.01180592,0.0005940294,0.0005995226,0.0004519206,0.0000407286,0.00005606333,0.0003145202,0.005055482,0.0001018041,0.001304205,0.01256014],"study_design_scores_gemma":[0.9378088,0.06022801,0.0009742153,0.00001695701,0.00009505841,0.0000229256,0.00000881966,0.0001717363,0.0002177173,0.00005505611,0.0003933017,0.000007442292],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9693891,0.004017436,0.001334226,0.0008661512,0.0005920409,0.01801971,0.002913455,0.0003193562,0.00254859],"genre_scores_gemma":[0.9619349,0.002456954,0.004034613,0.001786811,0.000560642,0.0222573,0.002478844,0.00004347165,0.004446558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009642081,"threshold_uncertainty_score":0.03225601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950620394","doi":"10.1097/01.hs9.0000561796.30124.a4","title":"S879 RESULTS OF ASTRAL‐1 STUDY, A PHASE 3 RANDOMIZED TRIAL OF GUADECITABINE (G) VS TREATMENT CHOICE (TC) IN TREATMENT NAÏVE ACUTE MYELOID LEUKEMIA (TN‐AML) NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (IC)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Decitabine; Internal medicine; Clinical endpoint; Cytarabine; Randomized controlled trial; Regimen; Induction chemotherapy; Oncology; Gastroenterology; Chemotherapy; Surgery","authors":[{"name":"Pierre Fenaux","is_ca":false},{"name":"Marco De Gobbi","is_ca":false},{"name":"Patricia Kropf","is_ca":false},{"name":"Jiřı́ Mayer","is_ca":false},{"name":"G.J. Roboz","is_ca":false},{"name":"Hartmut Döhner","is_ca":false},{"name":"J Krauter","is_ca":false},{"name":"Konstanze Döhner","is_ca":false},{"name":"Tadeusz Robak","is_ca":false},{"name":"H. Kantarjian","is_ca":false},{"name":"Jan Novák","is_ca":false},{"name":"W.W. Jedrzejczak","is_ca":false},{"name":"Xavier Thomas","is_ca":false},{"name":"Mario Ojeda‐Uribe","is_ca":false},{"name":"Yoshiyasu Miyazaki","is_ca":false},{"name":"Shih-Peng Yeh","is_ca":false},{"name":"Joseph Brandwein","is_ca":true},{"name":"Liana Gercheva","is_ca":false},{"name":"Judit Demeter","is_ca":false},{"name":"Ewen A. Griffiths","is_ca":false},{"name":"K Yee","is_ca":true},{"name":"Mohamed Azab","is_ca":false},{"name":"Jean‐Pierre J. Issa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03473661491423022,"gpt":0.3619602162914029,"spread":0.3272236013771727,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002077206,0.001294037,0.001736628,0.0003251756,0.0003345489,0.0008929562,0.0006341451,0.001439989,0.009629204],"category_scores_gemma":[0.002213608,0.0004254231,0.002196064,0.0003374406,0.0009000538,0.0008110308,0.0003684365,0.003772267,0.001265602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006361149,"about_ca_system_score_gemma":0.001011695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004857139,"about_ca_topic_score_gemma":0.001857528,"domain_scores_codex":[0.9991028,0.0006274724,0.0000442479,0.0001036221,0.00005427843,0.00006752045],"domain_scores_gemma":[0.998921,0.0003531549,0.0002790333,0.00007689342,0.00007055431,0.0002993876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9688325,0.00579984,0.0009968242,0.0006126182,0.001283235,0.00005349966,0.00006202088,0.0006006304,0.003566838,0.0002730132,0.003601247,0.01431783],"study_design_scores_gemma":[0.9138167,0.07791048,0.002538675,0.00006378719,0.001585833,0.00005562132,0.00003420951,0.0006354008,0.0006367973,0.0004625914,0.002240069,0.00001973163],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9722545,0.005431341,0.0008444068,0.002615678,0.0007890494,0.005949481,0.004753279,0.0001424104,0.007219819],"genre_scores_gemma":[0.9730958,0.002580498,0.002648714,0.003863403,0.0005550439,0.006883767,0.004612796,0.00007551897,0.005684505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009629204,"threshold_uncertainty_score":0.03221285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2953077540","doi":"10.1097/01.hs9.0000562152.07779.48","title":"PS962 PHASE 1 RESULTS OF ZUMA‐4: KTE‐X19, AN ANTI‐CD19 CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY, IN PEDIATRIC AND ADOLESCENT PATIENTS WITH RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Refractory (planetary science); Gastroenterology; Bone marrow; Acute lymphocytic leukemia; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Immunology; Leukemia; Lymphoblastic Leukemia; Biology","authors":[{"name":"Alan S. Wayne","is_ca":false},{"name":"Van Huynh","is_ca":true},{"name":"Nobuko Hijiya","is_ca":true},{"name":"Rayne H. Rouce","is_ca":true},{"name":"Patrick A. Brown","is_ca":false},{"name":"Joerg Krueger","is_ca":true},{"name":"Michael Rytting","is_ca":true},{"name":"Carrie L. Kitko","is_ca":false},{"name":"Edward Ziga","is_ca":true},{"name":"Michelle L. Hermiston","is_ca":true},{"name":"Morgan K. Richards","is_ca":false},{"name":"André Baruchel","is_ca":false},{"name":"Tong Shen","is_ca":true},{"name":"Lovely Goyal","is_ca":false},{"name":"Remus Vezan","is_ca":true},{"name":"Richa Jain","is_ca":true},{"name":"D.W. Lee","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00894242772849638,"gpt":0.2504569139496639,"spread":0.2415144862211675,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001199079,0.001129731,0.0008221988,0.0003657308,0.000338508,0.0006952811,0.0006094588,0.0007666825,0.002524734],"category_scores_gemma":[0.0005390276,0.0003271745,0.0006377982,0.000236127,0.0005307025,0.0005017022,0.0003452182,0.002217226,0.0006860459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007545358,"about_ca_system_score_gemma":0.001029249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007619841,"about_ca_topic_score_gemma":0.001353441,"domain_scores_codex":[0.9996401,0.0001942962,0.00001904418,0.00004048567,0.00004771069,0.00005837118],"domain_scores_gemma":[0.9996589,0.00006812101,0.00007182537,0.00003431618,0.00002845731,0.0001382709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3324326,0.1507504,0.02158614,0.0009393202,0.001316956,0.00119658,0.001206521,0.01724104,0.2635752,0.0008424173,0.0106373,0.1982756],"study_design_scores_gemma":[0.1619088,0.7228966,0.03541567,0.00005743624,0.0005225266,0.001611155,0.0001453974,0.004005265,0.06358527,0.000380244,0.009424715,0.00004701747],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955559,0.0007324691,0.0004544095,0.0001554679,0.00002444158,0.0008133231,0.0008628722,0.00005309732,0.001348039],"genre_scores_gemma":[0.9863278,0.001256679,0.001844982,0.0002934891,0.00006223437,0.001580976,0.004300758,0.00005032885,0.004282786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002524734,"threshold_uncertainty_score":0.008446097,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283326697","doi":"10.1097/01.hs9.0000843684.97625.7e","title":"S198: BET INHIBITOR PELABRESIB (CPI-0610) COMBINED WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS — JAK INHIBITOR-NAÏVE OR WITH SUBOPTIMAL RESPONSE TO RUXOLITINIB — PRELIMINARY DATA FROM THE MANIFEST STUDY","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Myeloproliferative neoplasm; Oncology; Bone marrow","authors":[{"name":"John Mascarenhas","is_ca":false},{"name":"Marina Kremyanskaya","is_ca":false},{"name":"Andrea Patriarca","is_ca":false},{"name":"Claire Harrison","is_ca":false},{"name":"Prithviraj Bose","is_ca":false},{"name":"Raajit K. Rampal","is_ca":false},{"name":"Francesca Palandri","is_ca":false},{"name":"Timothy Devos","is_ca":false},{"name":"Francesco Passamonti","is_ca":false},{"name":"Gabriella Hobbs","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Ronald Hoffman","is_ca":false},{"name":"Mohamed E. Salama","is_ca":false},{"name":"Dong Chen","is_ca":false},{"name":"Pietro Taverna","is_ca":false},{"name":"A. Chang","is_ca":false},{"name":"Gozde Colak","is_ca":false},{"name":"Sandra Klein","is_ca":false},{"name":"Vikas Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02699854354408923,"gpt":0.266576492253164,"spread":0.2395779487090748,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009799247,0.0006215119,0.001389343,0.0002605578,0.0002167649,0.000672474,0.0004160669,0.0006982547,0.005577995],"category_scores_gemma":[0.0008875871,0.0002122457,0.001379352,0.0003091416,0.0002317419,0.0005605707,0.0002401654,0.001533184,0.000903183],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005794866,"about_ca_system_score_gemma":0.0006668869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005901167,"about_ca_topic_score_gemma":0.002548539,"domain_scores_codex":[0.9997305,0.0001413892,0.00003003304,0.00003020388,0.00002821034,0.00003956064],"domain_scores_gemma":[0.999431,0.0001544209,0.0001332444,0.00003301039,0.00004421712,0.0002041621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6737611,0.01532267,0.01877739,0.001994815,0.003330992,0.0006330428,0.0001943826,0.001984168,0.03742528,0.0003048772,0.01139728,0.2348741],"study_design_scores_gemma":[0.4599499,0.418009,0.09069175,0.0004056327,0.003302097,0.001279246,0.0001428501,0.002204127,0.00564222,0.0004024919,0.01790351,0.00006722102],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9752339,0.01253038,0.0005716365,0.001821112,0.0002264925,0.0009147396,0.003215618,0.0001318098,0.005354277],"genre_scores_gemma":[0.9850642,0.004194775,0.0009688857,0.00163869,0.0002815026,0.0005426808,0.005129036,0.00002102742,0.002159161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005577995,"threshold_uncertainty_score":0.01866019,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386024051","doi":"10.1097/01.hs9.0000967672.15362.d7","title":"S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Health Services; McGill University","funders":"","keywords":"Medicine; Internal medicine; Multiple myeloma; Oncology; Lenalidomide; Regimen; Expanded access","authors":[{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Daniel Morillo","is_ca":false},{"name":"Moshe E. Gatt","is_ca":false},{"name":"Michaël Sébag","is_ca":true},{"name":"Kihyun Kım","is_ca":false},{"name":"Chang‐Ki Min","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Enrique M. Ocio","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Yaël C. Cohen","is_ca":false},{"name":"Michael Chu","is_ca":true},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Irit Avivi","is_ca":false},{"name":"Yue Guo","is_ca":false},{"name":"Maria Krevvata","is_ca":false},{"name":"Michelle Peterson","is_ca":false},{"name":"Melissa Beelen","is_ca":false},{"name":"Jill Vanak","is_ca":false},{"name":"Arnob Banerjee","is_ca":false},{"name":"Hila Magen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01469667351667762,"gpt":0.2448089160460415,"spread":0.2301122425293639,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001057837,0.0009292738,0.001530421,0.0002667705,0.0002567471,0.001046439,0.0004727925,0.0009747796,0.005318316],"category_scores_gemma":[0.0008282994,0.0003542318,0.001579863,0.0003236607,0.0004477179,0.0006916381,0.0003244034,0.002256377,0.001258597],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008124874,"about_ca_system_score_gemma":0.0008416582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006479745,"about_ca_topic_score_gemma":0.002427406,"domain_scores_codex":[0.9996673,0.0001562016,0.00002397531,0.00004138179,0.00004664449,0.00006457858],"domain_scores_gemma":[0.9995351,0.00008559738,0.0001061741,0.00003143587,0.00003762797,0.0002040928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7654962,0.02352407,0.0131641,0.001739263,0.003596883,0.0004925486,0.0003344858,0.001849806,0.03129159,0.000364002,0.01289729,0.1452498],"study_design_scores_gemma":[0.4893429,0.4582907,0.03116018,0.0001579042,0.002467147,0.0009408105,0.000117795,0.001154376,0.004706823,0.0003150367,0.01129153,0.00005485682],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827433,0.006130148,0.0004860241,0.001050762,0.0001830443,0.001280916,0.003703048,0.0001213722,0.004301506],"genre_scores_gemma":[0.9802106,0.003864062,0.0009926804,0.00166264,0.0003176766,0.0008511997,0.007487394,0.00005822072,0.004555516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005318316,"threshold_uncertainty_score":0.01779151,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950944873","doi":"10.1097/01.hs9.0000563756.72895.a3","title":"PS1370 ELOTUZUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: EFFICACY RESULTS AFTER ADDITIONAL FOLLOW‐UP OF THE PHASE 2, RANDOMIZED ELOQUENT‐3 STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Pomalidomide; Lenalidomide; Medicine; Internal medicine; Dexamethasone; Oncology; Multiple myeloma; Combination therapy; Ixazomib; Refractory (planetary science); Progression-free survival; Bortezomib; Overall survival; Carfilzomib","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Dominik Dytfeld","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Naoki Takezako","is_ca":false},{"name":"Mitsuo Hori","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Richard LeBlanc","is_ca":true},{"name":"Kazuyuki Suzuki","is_ca":false},{"name":"Marc‐Steffen Raab","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Mihaela Popa McKiver","is_ca":false},{"name":"Ying‐Ming Jou","is_ca":false},{"name":"Suresh G. Shelat","is_ca":false},{"name":"Michael Robbins","is_ca":false},{"name":"B. Rafferty","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02534817731838447,"gpt":0.3125158143310527,"spread":0.2871676370126683,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003160996,0.001303397,0.001897405,0.0004256822,0.0003267503,0.001540531,0.0008877787,0.001162513,0.003972691],"category_scores_gemma":[0.001736637,0.0004122273,0.0026133,0.0005403882,0.0008290776,0.001294911,0.0004522133,0.003412362,0.00108475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001429613,"about_ca_system_score_gemma":0.001224422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009082383,"about_ca_topic_score_gemma":0.002560784,"domain_scores_codex":[0.9991732,0.0004053692,0.0000419132,0.0001236659,0.0001129089,0.0001428273],"domain_scores_gemma":[0.9989892,0.0002334602,0.0002507698,0.00009872807,0.00008501992,0.0003428356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8318126,0.02089235,0.003713566,0.001174714,0.004105468,0.0001855282,0.0001933439,0.001857773,0.01093248,0.0004796419,0.006774798,0.1178777],"study_design_scores_gemma":[0.8352334,0.1393503,0.01514035,0.0001234032,0.002010387,0.0002819848,0.00007107649,0.001191047,0.001685241,0.0006097163,0.004254795,0.00004820112],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782462,0.01065791,0.0008577224,0.001385933,0.0003160805,0.001818675,0.003293253,0.0001824101,0.003241913],"genre_scores_gemma":[0.9830326,0.004126627,0.001448998,0.002264607,0.0003275484,0.001343903,0.005307801,0.00005788282,0.002090005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003972691,"threshold_uncertainty_score":0.01671714,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2949764170","doi":"10.1097/01.hs9.0000564104.83392.dc","title":"PS1460 LONG-TERM FOLLOW UP OF JAK INHIBITOR (JAKI) TREATED PATIENTS WITH MYELOFIBROSIS: IMPACT OF MOLECULAR ENHANCED INTEGRATED SCORING SYSTEMS AND TYPE OF JAKI THERAPY FAILURE ON SURVIVAL","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Myelofibrosis; Term (time); Medicine; Ruxolitinib; Internal medicine; Oncology; Physics","authors":[{"name":"J. Regis McNamara","is_ca":true},{"name":"Jennifer L. Spiegel","is_ca":false},{"name":"Wei Xu","is_ca":true},{"name":"Julianna Kennedy","is_ca":true},{"name":"Ana Luíza Ferreira de Arruda","is_ca":true},{"name":"Mengyao Yu","is_ca":true},{"name":"Jaime O. Claudio","is_ca":true},{"name":"Nancy Siddiq","is_ca":true},{"name":"Verna Cheung","is_ca":true},{"name":"Sabrina Malik","is_ca":true},{"name":"Anne Tierens","is_ca":true},{"name":"Dawn Maze","is_ca":true},{"name":"Hassan Sibai","is_ca":true},{"name":"Vedant Gupta","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01446729713172497,"gpt":0.2683572335645055,"spread":0.2538899364327805,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007507134,0.0001740954,0.000411603,0.0005195524,0.0003008635,0.00051079,0.0002675711,0.0003516689,0.001044473],"category_scores_gemma":[0.00143062,0.00009606411,0.0005176105,0.000593261,0.0001640096,0.00054038,0.0003460662,0.0004565121,0.0002265307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002755157,"about_ca_system_score_gemma":0.0002995978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008033331,"about_ca_topic_score_gemma":0.001279024,"domain_scores_codex":[0.9996994,0.00006315338,0.00003447094,0.00008314952,0.00006110251,0.0000587351],"domain_scores_gemma":[0.998811,0.0002623923,0.0004670957,0.00005411426,0.000105132,0.0003002707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00155295,0.00005873451,0.9939275,0.00001562089,0.00007619869,0.0001926637,0.00004038627,0.0002202148,0.0004979761,0.00001730852,0.00008901829,0.003311415],"study_design_scores_gemma":[0.00002733621,0.0009267282,0.9972994,0.000007902535,0.0001049121,0.0004000254,0.000046732,0.0007666149,0.0001476558,0.00005105563,0.0002154565,0.000006357821],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990183,0.0002877843,0.00009676372,0.00001969333,0.000004020053,0.000006389177,0.0002900323,0.00000214119,0.0002748656],"genre_scores_gemma":[0.9992066,0.00006756785,0.00004990458,0.00001170381,0.00001080799,0.000007970847,0.0005274255,0.00000100392,0.000116929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001044473,"threshold_uncertainty_score":0.003970265,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385644849","doi":"10.1097/01.hs9.0000967680.90062.ca","title":"S192: TALQUETAMAB (TAL) + DARATUMUMAB (DARA) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED TRIMM-2 RESULTS","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Internal medicine; Oncology; Refractory (planetary science); CD38; Gastroenterology; Lenalidomide; Multiple myeloma; CD34","authors":[{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Katja Weisel","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Tom Martin","is_ca":false},{"name":"Daniel Morillo","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Manisha Bhutani","is_ca":false},{"name":"Anita D’Souza","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Laura Rosiñol Dachs","is_ca":false},{"name":"Bhagirathbhai Dholaria","is_ca":false},{"name":"Kalpana Bakshi","is_ca":false},{"name":"Lijuan Kang","is_ca":false},{"name":"Lien Vandenberk","is_ca":false},{"name":"Damiette Smit","is_ca":false},{"name":"Ralph Wäsch","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"Ajai Chari","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02095778794704758,"gpt":0.2764088675186831,"spread":0.2554510795716355,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002198194,0.0004931265,0.001231924,0.0005372154,0.0001930314,0.001043714,0.0005906485,0.0005495831,0.00372992],"category_scores_gemma":[0.001510323,0.0001804658,0.00184896,0.0007991669,0.0001445328,0.0005455309,0.0004033104,0.000696841,0.0009927833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001006139,"about_ca_system_score_gemma":0.0007712013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001797965,"about_ca_topic_score_gemma":0.004624998,"domain_scores_codex":[0.9992716,0.0002557034,0.00009902759,0.0001012704,0.0001865123,0.00008595694],"domain_scores_gemma":[0.9989599,0.0002189602,0.0003398661,0.00004455888,0.0002468387,0.0001897982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08775925,0.001738688,0.1680615,0.006539288,0.01016088,0.0008684214,0.0003329404,0.003888804,0.01462071,0.0003245314,0.0538687,0.6518363],"study_design_scores_gemma":[0.02801028,0.05936745,0.6817443,0.002762839,0.02387847,0.005446217,0.0003678967,0.004639166,0.01358001,0.0006906331,0.1793257,0.0001871541],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8545604,0.09283523,0.00157151,0.004566837,0.0006554187,0.00103721,0.02370281,0.0003548721,0.02071577],"genre_scores_gemma":[0.9265093,0.02285862,0.003412579,0.004272564,0.0007700464,0.0005630814,0.03732314,0.0001124742,0.00417812],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00372992,"threshold_uncertainty_score":0.01247782,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386631797","doi":"10.1097/hs9.0000000000000953","title":"Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism","year":2023,"lang":"en","type":"editorial","venue":"HemaSphere","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Progenitor cell; Genetic enhancement; Stem cell; Haematopoiesis; Hematopoietic stem cell; Perspective (graphical); Bioinformatics; Cancer research; Progenitor; Biology; Gene; Medicine; Genetics; Computer science","authors":[{"name":"Francesca Tucci","is_ca":false},{"name":"Giulia Consiglieri","is_ca":false},{"name":"Matilde Cossutta","is_ca":false},{"name":"Maria Ester Bernardo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0220334038362064,"gpt":0.329828977943311,"spread":0.3077955741071046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002145211,0.0007777009,0.0009022364,0.000973913,0.0003283219,0.001909671,0.001190513,0.003787132,0.02801349],"category_scores_gemma":[0.001918107,0.0001554999,0.0008953959,0.0009347706,0.000795626,0.00280318,0.0007191618,0.004213078,0.00808581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009416595,"about_ca_system_score_gemma":0.001589199,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005135491,"about_ca_topic_score_gemma":0.001418467,"domain_scores_codex":[0.9993981,0.0001636522,0.00006317657,0.00009475058,0.0001917294,0.00008864314],"domain_scores_gemma":[0.9977005,0.0009923048,0.0001976353,0.00007459955,0.000584393,0.0004504879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004668327,0.0003315491,0.0004534285,0.003590974,0.00007175872,0.000455882,0.00006054498,0.0005643986,0.002756235,0.01106562,0.1344905,0.8456923],"study_design_scores_gemma":[0.00008127635,0.000437728,0.0007240001,0.001996443,0.00009626857,0.001429406,0.00009826931,0.0003378029,0.0008321925,0.006637783,0.9873037,0.0000251594],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.000977965,0.9399794,0.00301253,0.03167446,0.007862829,0.00004138838,0.0002307728,0.0001854188,0.01603533],"genre_scores_gemma":[0.006216629,0.9449776,0.004933626,0.01642863,0.01493314,0.00009389766,0.0004665363,0.00006213516,0.01188775],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.02801349,"threshold_uncertainty_score":0.09371448,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386024071","doi":"10.1097/01.hs9.0000967904.29417.23","title":"S248: SIERRA TRIAL RESULTS WITH A TARGETED RADIOTHERAPY, IOMAB-B, A MYELOABLATIVE CONDITIONING WITH REDUCED INTENSITY TOLERABILITY YIELDS HIGH CR, LONG TERM SURVIVAL IN HSCT INELIGIBLE ACTIVE R/R AML","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Tolerability; Internal medicine; Fludarabine; Clinical endpoint; Hematopoietic stem cell transplantation; Population; Oncology; Transplantation; Total body irradiation; Randomized controlled trial; Gastroenterology; Surgery; Adverse effect; Chemotherapy; Cyclophosphamide","authors":[{"name":"Boglarka Gyurkocza","is_ca":false},{"name":"Stuart Seropian","is_ca":false},{"name":"Hannah Choe","is_ca":false},{"name":"Mark R. Litzow","is_ca":false},{"name":"Camille N. Abboud","is_ca":false},{"name":"Nebu Koshy","is_ca":false},{"name":"Patrick J. Stiff","is_ca":false},{"name":"Benjamin Tomlinson","is_ca":false},{"name":"Sunil Abhyankar","is_ca":false},{"name":"James M. Foran","is_ca":false},{"name":"Parameswaran Hari","is_ca":false},{"name":"George L. Chen","is_ca":false},{"name":"Zaid Al‐Kadhimi","is_ca":false},{"name":"Partow Kebriaei","is_ca":false},{"name":"Mitchell Sabloff","is_ca":true},{"name":"Johnnie J. Orozco","is_ca":false},{"name":"Katarzyna Jamieson","is_ca":false},{"name":"Margarida Silverman","is_ca":false},{"name":"Koen van Besien","is_ca":false},{"name":"Michael Schuster","is_ca":false},{"name":"Arjun Law","is_ca":true},{"name":"Sameem Abedin","is_ca":false},{"name":"Karilyn Larkin","is_ca":false},{"name":"Scott D. Rowley","is_ca":false},{"name":"Pashna N. Munshi","is_ca":false},{"name":"Rachel J. Cook","is_ca":false},{"name":"Sebastian Mayer","is_ca":false},{"name":"Moshe Levy","is_ca":false},{"name":"Hillard M. Lazarus","is_ca":false},{"name":"Brenda M. Sandmaier","is_ca":false},{"name":"Vijay Reddy","is_ca":false},{"name":"Jennifer Spross","is_ca":false},{"name":"Kathleen McNamara","is_ca":false},{"name":"Elaina Haeuber","is_ca":false},{"name":"Madhuri Vusirikala","is_ca":false},{"name":"Akash Nahar","is_ca":false},{"name":"John M. Pagel","is_ca":false},{"name":"Sergio Giralt","is_ca":false},{"name":"Avinash Desai","is_ca":false},{"name":"Rajneesh Nath","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03122284311210522,"gpt":0.3114139022138427,"spread":0.2801910591017375,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009545156,0.0006538471,0.001056628,0.0002195436,0.0001692987,0.0009608705,0.0005391614,0.000837151,0.009356836],"category_scores_gemma":[0.0008810221,0.0002007345,0.001579147,0.0001853427,0.0004327887,0.0004315155,0.0002209118,0.00168854,0.001195833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003384481,"about_ca_system_score_gemma":0.0005634696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004170736,"about_ca_topic_score_gemma":0.001085575,"domain_scores_codex":[0.9997008,0.0001713068,0.00001929572,0.00004259125,0.00002391295,0.00004214638],"domain_scores_gemma":[0.9995366,0.0001087095,0.0001226972,0.00003660456,0.00002906837,0.0001662846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9461763,0.002685197,0.001804363,0.001200753,0.001083443,0.0001406296,0.00004630958,0.0005750383,0.01547697,0.0003861753,0.004991952,0.02543278],"study_design_scores_gemma":[0.8582559,0.1223086,0.008977583,0.0001494304,0.001766082,0.0003176493,0.00002641095,0.0005804904,0.002193268,0.000281706,0.005115758,0.00002701868],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9770885,0.007380227,0.0005177924,0.001404895,0.0004435816,0.002046391,0.00438388,0.000254961,0.006479916],"genre_scores_gemma":[0.9851785,0.001874717,0.000836049,0.001190017,0.0004363724,0.001292303,0.00444006,0.00003924667,0.004712554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009356836,"threshold_uncertainty_score":0.03130168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4382313481","doi":"10.1097/01.hs9.0000936256.84340.a7","title":"P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Multiple myeloma; Bone marrow; Internal medicine; CD8; Antibody; Oncology; Immunology; Immune system; Gastroenterology","authors":[{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"Diana Cortés‐Selva","is_ca":false},{"name":"Tineke Casneuf","is_ca":false},{"name":"Deeksha Vishwamitra","is_ca":false},{"name":"Sarah Stein","is_ca":false},{"name":"Tatiana Perova","is_ca":false},{"name":"Elena Ramos","is_ca":false},{"name":"Leen van Steenbergen","is_ca":false},{"name":"Olivia Lau","is_ca":false},{"name":"C. Davis","is_ca":false},{"name":"Arnob Banerjee","is_ca":false},{"name":"Tara Stephenson","is_ca":false},{"name":"Clarissa Uhlar","is_ca":false},{"name":"Rachel Kobos","is_ca":false},{"name":"Judith D. Goldberg","is_ca":false},{"name":"Lixia Pei","is_ca":false},{"name":"Danielle Trancucci","is_ca":false},{"name":"Suzette Girgis","is_ca":false},{"name":"Shun Xin Wang Lin","is_ca":false},{"name":"Lei Wu","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Raluca Verona","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03761353571323822,"gpt":0.3264041341039097,"spread":0.2887905983906714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001573125,0.000466349,0.0006073004,0.0005106656,0.0003041899,0.0005866896,0.0004501514,0.0004336828,0.0007838958],"category_scores_gemma":[0.0009332778,0.0002688222,0.0003486636,0.0003210947,0.0003615858,0.0003034486,0.0002549257,0.0009082581,0.000248601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006691971,"about_ca_system_score_gemma":0.0006438301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008959015,"about_ca_topic_score_gemma":0.001251459,"domain_scores_codex":[0.9996006,0.0001440753,0.00002570552,0.0001056431,0.00007791521,0.00004601568],"domain_scores_gemma":[0.9994809,0.0001094704,0.0001267307,0.00005363434,0.00007597096,0.000153219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1846933,0.01318889,0.3473343,0.000786218,0.001235726,0.001989979,0.0009466548,0.003125667,0.2590429,0.0003099295,0.004441277,0.1829053],"study_design_scores_gemma":[0.02575626,0.2179116,0.6829212,0.00005825651,0.001190961,0.005676518,0.0002755536,0.004822133,0.05116768,0.0002628246,0.0099015,0.00005557221],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972933,0.001221926,0.0001987812,0.00009403692,0.00001383402,0.0001825201,0.0003257756,0.00002582122,0.0006441198],"genre_scores_gemma":[0.9976877,0.000272138,0.00050826,0.0001643433,0.00004546997,0.00009954882,0.0008605929,0.000006438518,0.0003555816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001573125,"threshold_uncertainty_score":0.008319616,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385644723","doi":"10.1097/01.hs9.0000967696.13096.54","title":"S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Refractory (planetary science); Adverse effect; Gastroenterology; Multiple myeloma; Surgery","authors":[{"name":"Mohamad Mohty","is_ca":false},{"name":"Michael H. Tomasson","is_ca":false},{"name":"Bertrand Arnulf","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Cyrille Touzeau","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Julien Depaus","is_ca":false},{"name":"Hisayuki Yokoyama","is_ca":false},{"name":"Salomon Manier","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Marc S. Raab","is_ca":false},{"name":"Emma Searle","is_ca":false},{"name":"Eric Leip","is_ca":false},{"name":"Sharon T. Sullivan","is_ca":false},{"name":"Akos Czibere","is_ca":false},{"name":"Andrea Viqueira","is_ca":false},{"name":"Alexander M. Lesokhin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01863870885240338,"gpt":0.2789849677210768,"spread":0.2603462588686734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005676261,0.0002876681,0.0005645829,0.000165169,0.0002357532,0.0003157378,0.0003426049,0.0003372749,0.005269056],"category_scores_gemma":[0.0003342534,0.0001112329,0.0004986678,0.0002388148,0.0001738794,0.0002684995,0.000195574,0.0005884593,0.0008970321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005630908,"about_ca_system_score_gemma":0.0006442392,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005976987,"about_ca_topic_score_gemma":0.001654731,"domain_scores_codex":[0.9998608,0.00005110559,0.00001245795,0.00002430458,0.00002315977,0.00002821145],"domain_scores_gemma":[0.9998146,0.00003124932,0.00005652114,0.00001226735,0.00001332596,0.00007207879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.295438,0.007261954,0.09265249,0.001231552,0.001183982,0.00176607,0.0002165042,0.002141465,0.0955586,0.0003002553,0.01523795,0.4870111],"study_design_scores_gemma":[0.2906412,0.2573363,0.3612282,0.0002221121,0.001635508,0.005077405,0.0001200455,0.005373801,0.03227019,0.000477241,0.04555302,0.00006497036],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991583,0.002346819,0.0004800992,0.0005491285,0.00007042428,0.0004967529,0.001525078,0.00008166625,0.00286693],"genre_scores_gemma":[0.9932867,0.0006341347,0.0008222255,0.0004851836,0.0001208957,0.000263025,0.002580839,0.00001394318,0.001793106],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005269056,"threshold_uncertainty_score":0.0176267,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4401745029","doi":"10.1002/hem3.130","title":"Biomarkers of outcome in patients undergoing CD19 CAR‐T therapy for large B cell lymphoma","year":2024,"lang":"en","type":"review","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"University of Toronto","keywords":"Chimeric antigen receptor; Chemoimmunotherapy; Medicine; Oncology; Refractory (planetary science); Lymphoma; Internal medicine; CD19; Disease; Immunotherapy; Antigen; Immunology; Rituximab; Cancer; Biology","authors":[{"name":"Inna Y. Gong","is_ca":true},{"name":"Daisy Tran","is_ca":true},{"name":"Samuel D. Saibil","is_ca":true},{"name":"Rob C. Laister","is_ca":true},{"name":"John Kuruvilla","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06631002535945682,"gpt":0.379980524641565,"spread":0.3136704992821082,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007900338,0.0006299957,0.001621582,0.001109736,0.00009974039,0.000535982,0.0004434448,0.0005413794,0.000855151],"category_scores_gemma":[0.001335612,0.0001497181,0.0007472083,0.0011033,0.0001880205,0.000392119,0.0002826947,0.0007852524,0.0003159456],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003572624,"about_ca_system_score_gemma":0.0005877477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007479428,"about_ca_topic_score_gemma":0.001264656,"domain_scores_codex":[0.9997677,0.00007742672,0.00004151906,0.00003530098,0.00005910369,0.00001893208],"domain_scores_gemma":[0.99949,0.0002921599,0.000102928,0.000007570329,0.00009057694,0.00001673145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004338089,0.00006690979,0.0031035,0.01929086,0.0007436246,0.00009782501,0.00003987136,0.0002833929,0.001068713,0.0005209886,0.008298965,0.9660515],"study_design_scores_gemma":[0.0007066741,0.003121473,0.09612399,0.06481999,0.01322852,0.006629792,0.0004072013,0.001386568,0.005384746,0.004136662,0.8038146,0.0002396723],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005491593,0.9989436,0.00005495905,0.0001241034,0.00005498081,0.000004747701,0.00003052125,0.000002890701,0.0002350424],"genre_scores_gemma":[0.004958005,0.9943558,0.0001776609,0.0001542746,0.00008824789,0.00001930281,0.0000768303,9.731376e-7,0.0001689297],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001621582,"threshold_uncertainty_score":0.004178107,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950984087","doi":"10.1097/01.hs9.0000563784.11014.52","title":"PS1377 IMPROVEMENT IN HEALTH‐RELATED QUALITY OF LIFE FOR NEWLY DIAGNOSED MULTIPLE MYELOMA TRANSPLANT‐ELIGIBLE PATIENTS TREATED WITH DARATUMUMAB, BORTEZOMIB, THALIDOMIDE, AND DEXAMETHASONE: CASSIOPEIA STUDY","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Saskatchewan; Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Hotel Dieu Hospital","funders":"","keywords":"Medicine; Daratumumab; Bortezomib; Multiple myeloma; Internal medicine; Autologous stem-cell transplantation; Oncology","authors":[{"name":"Murielle Roussel","is_ca":false},{"name":"Philippe Moreau","is_ca":true},{"name":"Michel Attal","is_ca":false},{"name":"Jean‐Claude Eisenmann","is_ca":false},{"name":"Kamel Laribi","is_ca":false},{"name":"Arnaud Jaccard","is_ca":false},{"name":"M. Dib","is_ca":true},{"name":"Borhane Slama","is_ca":true},{"name":"Carine Chaleteix","is_ca":true},{"name":"Véronique Dorvaux","is_ca":false},{"name":"Bruno Royer","is_ca":true},{"name":"Laurent Frenzel","is_ca":true},{"name":"Sonja Zweegman","is_ca":true},{"name":"Saskia K. Klein","is_ca":true},{"name":"Annemiek Broijl","is_ca":false},{"name":"K.‐S. Jie","is_ca":false},{"name":"C. Araujo","is_ca":true},{"name":"Véronique Vanquickelberghe","is_ca":true},{"name":"Carla de Boer","is_ca":true},{"name":"Tobias Kampfenkel","is_ca":false},{"name":"Jessica Vermeulen","is_ca":true},{"name":"C. McKay","is_ca":true},{"name":"Katharine S. Gries","is_ca":false},{"name":"Jeremiah Trudeau","is_ca":true},{"name":"Pieter Sonneveld","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03098393264413396,"gpt":0.3156171613640681,"spread":0.2846332287199341,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001255479,0.0006357078,0.001430625,0.0001797056,0.0003052014,0.000823321,0.0004651734,0.0006845985,0.002477855],"category_scores_gemma":[0.0008104904,0.0002697043,0.00187813,0.0003921225,0.0004541821,0.0003774752,0.0004500853,0.001520317,0.0004309492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008127816,"about_ca_system_score_gemma":0.001639087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001680663,"about_ca_topic_score_gemma":0.003312716,"domain_scores_codex":[0.9996523,0.0001484,0.00002360983,0.00006784644,0.00005870658,0.00004912917],"domain_scores_gemma":[0.9991146,0.0001130132,0.000252465,0.00006248709,0.00006037806,0.0003970802],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8164306,0.0175916,0.08942728,0.0006516154,0.005637387,0.0002061136,0.0001958451,0.00137247,0.0121258,0.0002037967,0.002582212,0.05357523],"study_design_scores_gemma":[0.4297299,0.2352685,0.3224842,0.00007716068,0.004544662,0.0003291949,0.0001415528,0.001587632,0.002484655,0.0002078334,0.00308601,0.00005863311],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9980567,0.0005584624,0.00006841353,0.0001677831,0.00003447708,0.0002209627,0.0004888747,0.000008593267,0.0003957698],"genre_scores_gemma":[0.9968715,0.0004724414,0.0001969691,0.0003334587,0.0000793123,0.0003363565,0.001072879,0.000003609831,0.0006335071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002477855,"threshold_uncertainty_score":0.008289278,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3005555374","doi":"10.1097/01.hs9.0000563932.34778.38","title":"PS1414 A PHASE 1B/2 STUDY OF SELINEXOR, CARFILZOMIB, AND DEXAMETHASONE (SKD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Maisonneuve-Rosemont; Vancouver General Hospital; CancerCare Manitoba; Royal Victoria Hospital; Dalhousie University; Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Medicine; Carfilzomib; Internal medicine; Refractory (planetary science); Dexamethasone; Oncology; Phases of clinical research; Gastroenterology; Multiple myeloma; Lenalidomide; Adverse effect; Pharmacology; Chemotherapy","authors":[{"name":"Cristina Gasparetto","is_ca":false},{"name":"Suzanne Lentzsch","is_ca":false},{"name":"Gary J. Schiller","is_ca":false},{"name":"Natalie S. Callander","is_ca":false},{"name":"C. Chen","is_ca":true},{"name":"Darrell White","is_ca":true},{"name":"Rami Kotb","is_ca":true},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Michaël Sébag","is_ca":true},{"name":"Sascha A. Tuchman","is_ca":false},{"name":"Muhamed Baljević","is_ca":false},{"name":"Jack W. Singer","is_ca":false},{"name":"Richard LeBlanc","is_ca":true},{"name":"Chris Venner","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":false},{"name":"Karla Rodriguez-Lopez","is_ca":false},{"name":"Heidi Sheehan","is_ca":false},{"name":"Jean-Richard Saint-Martin","is_ca":false},{"name":"Jatin J. Shah","is_ca":false},{"name":"Sharon Shacham","is_ca":false},{"name":"Michael Kauffman","is_ca":false},{"name":"Brea Lipe","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02940570002004456,"gpt":0.328572253292662,"spread":0.2991665532726175,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002116852,0.00193044,0.001538498,0.0006527154,0.0005532467,0.0009807714,0.001124745,0.001245999,0.005855421],"category_scores_gemma":[0.0007005619,0.0007064487,0.001284709,0.0004155419,0.0008115256,0.0007989925,0.0004714756,0.003047301,0.001170205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001150446,"about_ca_system_score_gemma":0.002367337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001298717,"about_ca_topic_score_gemma":0.003773423,"domain_scores_codex":[0.9995137,0.0002551053,0.00002102538,0.0000671089,0.00006433202,0.00007875571],"domain_scores_gemma":[0.9994357,0.00006883741,0.00009227457,0.00004048843,0.0000445329,0.0003181844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4906806,0.1751243,0.01201758,0.00160683,0.002148243,0.0005761239,0.0006158485,0.005294954,0.1181133,0.0007024898,0.01130659,0.1818131],"study_design_scores_gemma":[0.494006,0.4815563,0.01124186,0.00003767633,0.0004422988,0.0004707874,0.00006633302,0.001293903,0.0057821,0.0002518917,0.004819438,0.00003137195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987849,0.001725042,0.0007611184,0.0008188199,0.0001180287,0.004958813,0.00148272,0.0001751073,0.002111435],"genre_scores_gemma":[0.975611,0.002407174,0.003922016,0.001661501,0.0002021863,0.005488329,0.004158848,0.00007228004,0.006476627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005855421,"threshold_uncertainty_score":0.01958829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385707295","doi":"10.1097/01.hs9.0000970420.62475.d0","title":"P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Multiple myeloma; Daratumumab; Cytokine release syndrome; Oncology; Bortezomib; Refractory (planetary science); Gastroenterology; Surgery; Cancer; Clinical trial; Immunotherapy; Chimeric antigen receptor","authors":[{"name":"Surbhi Sidana","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Alfred L. Garfall","is_ca":false},{"name":"Manisha Bhutani","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Ajay K. Nooka","is_ca":false},{"name":"Tom Martin","is_ca":false},{"name":"Laura Rosiñol Dachs","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Rakesh Popat","is_ca":false},{"name":"Britta Besemer","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Amrita Krishnan","is_ca":false},{"name":"Michel Delforge","is_ca":false},{"name":"Danielle Trancucci","is_ca":false},{"name":"Raluca Verona","is_ca":false},{"name":"Tara Stephenson","is_ca":false},{"name":"Katherine Chastain","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01996740738613229,"gpt":0.2765928248278406,"spread":0.2566254174417083,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381176,0.0002714296,0.0008852687,0.0003096829,0.0005945915,0.000957986,0.0004426485,0.0006742596,0.00191081],"category_scores_gemma":[0.001349585,0.0001908053,0.001072674,0.0004630724,0.0002381783,0.000723254,0.0006757002,0.001416979,0.0005233311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009369556,"about_ca_system_score_gemma":0.0008068998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001591666,"about_ca_topic_score_gemma":0.002924607,"domain_scores_codex":[0.9995796,0.0001027168,0.00004662959,0.000102432,0.00006246707,0.0001061678],"domain_scores_gemma":[0.998941,0.0001651045,0.0002858837,0.00009463294,0.0001173076,0.0003960299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1809054,0.004855456,0.5215905,0.001006755,0.003598852,0.00339169,0.0008530457,0.001899803,0.008117063,0.0003061125,0.0203313,0.2531441],"study_design_scores_gemma":[0.01573175,0.07060373,0.8800316,0.000389782,0.003509937,0.002753292,0.0003284324,0.001693367,0.00228039,0.0004414149,0.02216004,0.0000761566],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892764,0.00438969,0.0003485844,0.0005580942,0.000100086,0.0002040859,0.002926739,0.00003620429,0.002160135],"genre_scores_gemma":[0.990001,0.001020502,0.0002911062,0.0009169909,0.0001350602,0.0001871747,0.006184685,0.00001135421,0.001252184],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00191081,"threshold_uncertainty_score":0.00730443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4398185210","doi":"10.1002/hem3.69","title":"Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)","year":2024,"lang":"en","type":"review","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Myelodysplastic syndromes; Medicine; Drug development; Clinical trial; Drug; Intensive care medicine; Oncology; Medical physics; Internal medicine; Pharmacology; Bone marrow","authors":[{"name":"Fabio Efficace","is_ca":false},{"name":"Rena Buckstein","is_ca":true},{"name":"Gregory A. Abel","is_ca":false},{"name":"Johannes M. Giesinger","is_ca":false},{"name":"Pierre Fenaux","is_ca":false},{"name":"Jan Philipp Bewersdorf","is_ca":false},{"name":"Andrew M. Brunner","is_ca":false},{"name":"Rafael Bejar","is_ca":false},{"name":"Uma Borate","is_ca":false},{"name":"Amy E. DeZern","is_ca":false},{"name":"Peter L. Greenberg","is_ca":false},{"name":"Gail J. Roboz","is_ca":false},{"name":"Michael R. Savona","is_ca":false},{"name":"Francesco Sparano","is_ca":false},{"name":"Jacqueline Boultwood","is_ca":false},{"name":"Rami S. Komrokji","is_ca":false},{"name":"David A. Sallman","is_ca":false},{"name":"Zhuoer Xie","is_ca":false},{"name":"Guillermo Sanz","is_ca":false},{"name":"Hetty E. Carraway","is_ca":false},{"name":"Justin Taylor","is_ca":false},{"name":"Stephen D. Nimer","is_ca":false},{"name":"Matteo Giovanni Della Porta","is_ca":false},{"name":"Valeria Santini","is_ca":false},{"name":"Maximilian Stahl","is_ca":false},{"name":"Uwe Platzbecker","is_ca":false},{"name":"Mikkael A. Sekeres","is_ca":false},{"name":"Amer M. Zeidan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2713230922332107,"gpt":0.483135307900352,"spread":0.2118122156671414,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1706289,0.001264302,0.005645784,0.002705527,0.0008664631,0.009126789,0.004102163,0.007487558,0.003921531],"category_scores_gemma":[0.1665929,0.001004145,0.004243795,0.003363096,0.004093295,0.01242714,0.003007597,0.0163354,0.00195879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003319123,"about_ca_system_score_gemma":0.02536221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001413455,"about_ca_topic_score_gemma":0.003062057,"domain_scores_codex":[0.908231,0.0731556,0.008147934,0.002149532,0.007728297,0.0005877166],"domain_scores_gemma":[0.6733712,0.2818648,0.01425107,0.006239533,0.0208269,0.003446524],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0004426307,0.000235826,0.0003437648,0.04880895,0.0005888275,0.0001416724,0.0006604273,0.001079791,0.0004970701,0.04501853,0.04632168,0.8558608],"study_design_scores_gemma":[0.002074908,0.00111233,0.001376512,0.1104192,0.00151831,0.0007298045,0.0006023622,0.001694017,0.000736651,0.06226936,0.8173015,0.0001650273],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003903121,0.8763211,0.01642372,0.09949234,0.002338785,0.001372181,0.0001425126,0.0001567757,0.003362218],"genre_scores_gemma":[0.009781757,0.781853,0.1299947,0.06732142,0.004138789,0.005086059,0.0002106895,0.0001376802,0.00147599],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8293711,"threshold_uncertainty_score":0.9023827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2924768710","doi":"10.1097/hs9.0000000000000233","title":"AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Discovery Centre","funders":"Blood Cancer UK; Medical Research Council; Bloodwise; Cancer Research UK","keywords":"Myeloproliferative neoplasm; Essential thrombocythemia; Polycythemia vera; Myeloid leukemia; Cancer research; Thrombopoietin receptor; Janus kinase 2; Myeloproliferative Disorders; Myelofibrosis; Tyrosine kinase; Stem cell; Haematopoiesis; Myeloid; Medicine; Polycythaemia; Biology; Immunology; Internal medicine; Receptor; Bone marrow; Thrombopoietin; Genetics","authors":[{"name":"Stella Pearson","is_ca":false},{"name":"Rognvald Blance","is_ca":false},{"name":"Tim C. P. Somervaille","is_ca":false},{"name":"Anthony D. Whetton","is_ca":true},{"name":"Andrew Pierce","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007214455750966063,"gpt":0.2344571461380814,"spread":0.2272426903871153,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000442549,0.0001726137,0.0001121642,0.0001381649,0.00008910922,0.0001513083,0.0001119032,0.0001294295,0.001463127],"category_scores_gemma":[0.00003146726,0.00004296043,0.00008005532,0.00008913548,0.00007350788,0.0001205596,0.00009721686,0.0003954278,0.0002472581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000140593,"about_ca_system_score_gemma":0.0001201336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001897596,"about_ca_topic_score_gemma":0.0005075979,"domain_scores_codex":[0.999954,0.000004566194,0.000002865258,0.000007877263,0.00001984287,0.00001094146],"domain_scores_gemma":[0.9999812,0.000003691937,0.000004070173,0.00000163765,0.000002310325,0.000007165578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001479543,0.000100088,0.0001410911,0.0000400101,0.00000486117,0.00005931296,0.00001057141,0.0001026161,0.9943213,0.0001307756,0.0001528636,0.004788507],"study_design_scores_gemma":[0.00003225053,0.0008240773,0.00437741,0.000004080496,0.000008795129,0.0002603935,0.00001353113,0.0009960619,0.9885346,0.00006066447,0.004885007,0.000002987841],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941713,0.001411589,0.001374764,0.0001205566,0.00003494012,0.00003662262,0.000492896,0.00009715441,0.00226003],"genre_scores_gemma":[0.9946254,0.0009507811,0.001235844,0.00007189889,0.0000092527,0.00002790925,0.0006799675,0.000007212493,0.002391719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001463127,"threshold_uncertainty_score":0.004894614,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4225775959","doi":"10.1097/hs9.0000000000000705","title":"Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal Origin","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Lymphoma; Diffuse large B-cell lymphoma; Germinal center; Medicine; Internal medicine; Oncology; Cancer research; Pathology; B cell; Immunology; Antibody","authors":[{"name":"Waleed Alduaij","is_ca":true},{"name":"Laura K. Hilton","is_ca":true},{"name":"Muntadhar Al Moosawi","is_ca":true},{"name":"Susana Ben‐Neriah","is_ca":true},{"name":"Barbara Meissner","is_ca":true},{"name":"Merrill Boyle","is_ca":true},{"name":"Kelly Mekwunye","is_ca":true},{"name":"David W. Scott","is_ca":true},{"name":"Heather A. Leitch","is_ca":true},{"name":"Jeffrey W. Craig","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02752703303518759,"gpt":0.2662789280037343,"spread":0.2387518949685467,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005540221,0.002380546,0.001773957,0.004168532,0.002967704,0.003038647,0.002026341,0.003092894,0.004585465],"category_scores_gemma":[0.0038404,0.001357061,0.00114902,0.00310935,0.002438151,0.002879339,0.0046252,0.003410144,0.001647045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001886247,"about_ca_system_score_gemma":0.001158481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003758771,"about_ca_topic_score_gemma":0.004804009,"domain_scores_codex":[0.9987605,0.00009326469,0.0001368416,0.0003754207,0.0002037001,0.0004303924],"domain_scores_gemma":[0.9969549,0.0006538974,0.0006096108,0.000607332,0.0002392145,0.0009350133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0001040034,0.00008609711,0.0275812,0.000118824,0.00002708267,0.9610611,0.0003390846,0.000135522,0.002378648,0.0007842432,0.0007806878,0.006603587],"study_design_scores_gemma":[0.00001514514,0.00002724137,0.00350951,0.0000174655,0.00001977776,0.9944812,0.000105659,0.0002404656,0.0004817226,0.0003045983,0.0007865521,0.00001075159],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9438536,0.01069334,0.01330188,0.001745707,0.0003686282,0.0006685099,0.0008501245,0.0008219911,0.02769617],"genre_scores_gemma":[0.991531,0.001143823,0.004067002,0.000994512,0.0005278865,0.00006599994,0.0002789603,0.00007833353,0.001312473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004585465,"threshold_uncertainty_score":0.01533997,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4408845598","doi":"10.1002/hem3.70106","title":"Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health survey","year":2025,"lang":"en","type":"article","venue":"HemaSphere","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; University of British Columbia","funders":"AOP Orphan; Astellas Pharma; Galecto; Sierra Oncology; Incyte; CTI Biopharma; BeiGene; Bristol-Myers Squibb; AstraZeneca; CSL Behring; MPN Research Foundation; Alexion Pharmaceuticals; Gilead Sciences; Sanofi; GlaxoSmithKline; Pfizer; Novartis Pharmaceuticals Corporation; Celgene","keywords":"Medicine; Depression (economics); Myeloproliferative neoplasm; Quality of life (healthcare); Polycythemia vera; Family medicine; Disease; Physical therapy; Emergency medicine; Internal medicine; Myelofibrosis","authors":[{"name":"Claire Harrison","is_ca":false},{"name":"David M. Ross","is_ca":false},{"name":"Laura Fogliatto","is_ca":false},{"name":"Lynda Foltz","is_ca":true},{"name":"Lambert Busque","is_ca":true},{"name":"Zhijian Xiao","is_ca":false},{"name":"Florian H. Heidel","is_ca":false},{"name":"Michael Koehler","is_ca":false},{"name":"Giuseppe A. Palumbo","is_ca":false},{"name":"Massimo Breccia","is_ca":false},{"name":"Norio Komatsu","is_ca":false},{"name":"Keita Kirito","is_ca":false},{"name":"Blanca Xicoy Cirici","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Alicia Rovó","is_ca":false},{"name":"Cheryl Petruk","is_ca":false},{"name":"Catalin Bobirca","is_ca":false},{"name":"Laura Mirams","is_ca":false},{"name":"Abigail McMillan","is_ca":false},{"name":"Gavin Harper","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01158140979650688,"gpt":0.3007316178053178,"spread":0.2891502080088109,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003135885,0.0001352987,0.0002819599,0.0005542075,0.0003131802,0.0006270919,0.0002055359,0.0004878327,0.0009473134],"category_scores_gemma":[0.009330328,0.0001243485,0.0005130747,0.0007290964,0.0003244136,0.0004525227,0.0005832777,0.0007180743,0.0001651728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005861028,"about_ca_system_score_gemma":0.0004378763,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00834824,"about_ca_topic_score_gemma":0.007651353,"domain_scores_codex":[0.9978478,0.001194522,0.0002378826,0.0001021828,0.0003764818,0.0002411387],"domain_scores_gemma":[0.9914533,0.002489906,0.003800692,0.0001379893,0.0009183703,0.001199873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00009006399,0.00008200255,0.992569,0.00005560494,0.00005122255,0.00005328283,0.001591355,0.0001043523,0.00008289016,0.00002555941,0.0007889908,0.004505569],"study_design_scores_gemma":[0.000007197671,0.0001514638,0.996565,0.00002606089,0.00001216538,0.00007741732,0.00233395,0.0001750165,0.00002436279,0.00001858728,0.0006007153,0.000007975548],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964961,0.0004009016,0.00006855227,0.0008260632,0.00001278101,0.00002593587,0.0007498825,0.000005589119,0.001414149],"genre_scores_gemma":[0.998879,0.0002079051,0.0001075186,0.0002432904,0.00001369708,0.00001779162,0.0004340637,0.000001538136,0.00009522465],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00834824,"threshold_uncertainty_score":0.0165993,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404813541","doi":"10.1002/hem3.70001","title":"Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma","year":2024,"lang":"en","type":"article","venue":"HemaSphere","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Veterinärmedizinische Universität Wien; Universität Wien; Christian Doppler Forschungsgesellschaft; Vienna Science and Technology Fund; Austrian Science Fund; Medizinische Universität Wien; European Commission; Siemens Medical Solutions USA","keywords":"Myeloid leukemia; Dual (grammatical number); Lymphoma; Block (permutation group theory); Cancer research; Acute leukemia; Leukemia; Medicine; Immunology; Mathematics","authors":[{"name":"Daniel Pölöske","is_ca":false},{"name":"Helena Sorger","is_ca":false},{"name":"Anna Schönbichler","is_ca":false},{"name":"Elvin D. de Araujo","is_ca":true},{"name":"Heidi A. Neubauer","is_ca":false},{"name":"Anna Orlova","is_ca":false},{"name":"Sanna Timonen","is_ca":false},{"name":"Diaaeldin I. Abdallah","is_ca":true},{"name":"Aleksandr Ianevski","is_ca":false},{"name":"Heikki Kuusanmäki","is_ca":false},{"name":"Marta Surbek","is_ca":false},{"name":"Elizabeth Heyes","is_ca":false},{"name":"Thomas Eder","is_ca":false},{"name":"Christina Wagner","is_ca":false},{"name":"Tobias Suske","is_ca":false},{"name":"Martin Metzelder","is_ca":false},{"name":"Michael Bergmann","is_ca":false},{"name":"Maik Dahlhoff","is_ca":false},{"name":"Florian Grebien","is_ca":false},{"name":"Roman Fleck","is_ca":false},{"name":"Christine Pirker","is_ca":false},{"name":"Walter Berger","is_ca":false},{"name":"Emir Hadzijusufovic","is_ca":false},{"name":"Wolfgang R. Sperr","is_ca":false},{"name":"Lukas Kenner","is_ca":false},{"name":"Peter Valent","is_ca":false},{"name":"Tero Aittokallio","is_ca":false},{"name":"Marco Herling","is_ca":false},{"name":"Satu Mustjoki","is_ca":false},{"name":"Patrick T. Gunning","is_ca":true},{"name":"Richard Moriggl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01169715660341519,"gpt":0.2629680298935974,"spread":0.2512708732901822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001213486,0.0003571138,0.0002332057,0.0002599593,0.00008096679,0.0001905777,0.000181985,0.0002105642,0.001051383],"category_scores_gemma":[0.00007697261,0.0001288315,0.0002351228,0.0001800189,0.0001601555,0.0001407766,0.0001256732,0.0004658525,0.0002887639],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002116376,"about_ca_system_score_gemma":0.0003059655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004943381,"about_ca_topic_score_gemma":0.00139781,"domain_scores_codex":[0.9998851,0.00001939804,0.00001240802,0.00001776174,0.00003257949,0.00003278191],"domain_scores_gemma":[0.9999477,0.000009403868,0.00001225934,0.00000677033,0.000004993728,0.00001885543],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003532754,0.0001361071,0.0002185668,0.00005502465,0.00001522199,0.00004172368,0.00001281989,0.0003480884,0.9926898,0.0001911922,0.0001492758,0.005788927],"study_design_scores_gemma":[0.0001010239,0.002946575,0.002366215,0.000004440412,0.0000344204,0.0002888456,0.00001370331,0.001443363,0.9906342,0.00003544105,0.002125882,0.000005934979],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936234,0.001631018,0.002219972,0.00005466072,0.00002313417,0.00004727361,0.0003014131,0.000140605,0.001958502],"genre_scores_gemma":[0.9941981,0.0009902982,0.002269385,0.00004527836,0.000006225439,0.00004546,0.000597612,0.00001546448,0.001832187],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001051383,"threshold_uncertainty_score":0.00351727,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2950604500","doi":"10.1097/01.hs9.0000562556.40615.f8","title":"PS1065 OPEN‐LABEL STUDY OF GILTERITINIB, GILTERITINIB PLUS AZACITIDINE, OR AZACITIDINE ALONE IN NEWLY DIAGNOSED FLT3‐MUTATED AML PATIENTS INELIGIBLE FOR INTENSIVE CHEMOTHERAPY: RESULTS FROM THE SAFETY COHORT","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Cohort; Chemotherapy; Surgery; Internal medicine; Gastroenterology; Adverse effect","authors":[{"name":"Jordi Esteve","is_ca":false},{"name":"Rik Schots","is_ca":false},{"name":"Jeong Hoon Lee","is_ca":false},{"name":"E. Wang","is_ca":false},{"name":"Shira Dinner","is_ca":false},{"name":"Mark D. Minden","is_ca":true},{"name":"Olga Salamero","is_ca":false},{"name":"Jorge Sierra","is_ca":false},{"name":"Gabriela Yoshimoto","is_ca":false},{"name":"Kamel Laribi","is_ca":false},{"name":"Janusz Hałka","is_ca":false},{"name":"Pau Montesinos","is_ca":false},{"name":"S. Liu","is_ca":false},{"name":"Elizabeth Rich","is_ca":false},{"name":"Erkut Bahceci","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04942912092761675,"gpt":0.3420307488687258,"spread":0.292601627941109,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002282433,0.002228869,0.00317762,0.0006064186,0.0005272042,0.001228856,0.0009743627,0.001572161,0.006067828],"category_scores_gemma":[0.001339004,0.0007183128,0.002653505,0.0004909683,0.001651712,0.001516409,0.0005702304,0.004209987,0.001422944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001296094,"about_ca_system_score_gemma":0.002130976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001060409,"about_ca_topic_score_gemma":0.002323424,"domain_scores_codex":[0.9991806,0.0003737654,0.00004768762,0.0001811098,0.00008198124,0.0001349085],"domain_scores_gemma":[0.998494,0.0002283958,0.0002922693,0.0001376927,0.00009512142,0.0007525273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9371862,0.02771243,0.00511622,0.0002382233,0.00129695,0.0001429202,0.0001065541,0.0008226244,0.007078584,0.0001056611,0.001657491,0.01853626],"study_design_scores_gemma":[0.6404585,0.3388728,0.01605798,0.00002032739,0.0008255874,0.0001517583,0.00005000392,0.0007399851,0.001218966,0.0001581416,0.001411945,0.00003406116],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933216,0.0008672475,0.000323322,0.0002902292,0.000134738,0.001330853,0.002292901,0.00007583459,0.001363337],"genre_scores_gemma":[0.9873819,0.0009489953,0.0008664594,0.0008666718,0.0004172944,0.001699919,0.00535313,0.00002437638,0.002441369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006067828,"threshold_uncertainty_score":0.02029896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4283392950","doi":"10.1097/01.hs9.0000847476.69621.cd","title":"P1152: RESULTS FROM A PHASE I PHARMACOKINETIC (PK) AND SAFETY STUDY OF TRPH-222, A NOVEL CD22-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA (R/R NHL)","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tolerability; Pharmacokinetics; Antibody-drug conjugate; Internal medicine; Cmax; Refractory (planetary science); Phases of clinical research; Gastroenterology; Lymphoma; Oncology; Antibody; Pharmacology; Toxicity; Adverse effect; Monoclonal antibody; Immunology","authors":[{"name":"Francisco J. Hernandez‐Ilizaliturri","is_ca":false},{"name":"John Kuruvilla","is_ca":true},{"name":"Beth Christian","is_ca":false},{"name":"Ian W. Flinn","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"Matthew L. Ulrickson","is_ca":false},{"name":"Daniel J. Landsburg","is_ca":false},{"name":"H. Lowman","is_ca":false},{"name":"N. Levin","is_ca":false},{"name":"D. Maetzel","is_ca":false},{"name":"N. N. Viller","is_ca":false},{"name":"A. MacLaren","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0126925416239034,"gpt":0.2900373408021528,"spread":0.2773447991782494,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001131587,0.0009287666,0.000969891,0.0002576225,0.0003069499,0.0008982174,0.0004795006,0.0006356331,0.001474634],"category_scores_gemma":[0.0007462715,0.0003163766,0.0006152525,0.0002773019,0.0006629403,0.00055511,0.0002369561,0.001821731,0.0005246271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007082948,"about_ca_system_score_gemma":0.0007827262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008074985,"about_ca_topic_score_gemma":0.001284449,"domain_scores_codex":[0.9996752,0.0001467212,0.00001795028,0.00006013649,0.00004475451,0.0000552548],"domain_scores_gemma":[0.9994943,0.00009530266,0.0001005339,0.00005295056,0.00003879366,0.0002180233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2645246,0.1211778,0.03163755,0.000864737,0.001788946,0.001589726,0.001162422,0.007560436,0.3343591,0.0003590159,0.006223222,0.2287525],"study_design_scores_gemma":[0.1215625,0.7594804,0.05660569,0.00003571452,0.001074639,0.001901004,0.0001722202,0.004787802,0.04858062,0.0002194383,0.005512042,0.00006788293],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966699,0.0007368517,0.0008077049,0.0001047659,0.00001795333,0.0004312244,0.0004417584,0.00008194449,0.0007079272],"genre_scores_gemma":[0.9954001,0.0004806635,0.0009383716,0.0002554927,0.00004885194,0.0003072839,0.001582067,0.00003428449,0.0009528016],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001474634,"threshold_uncertainty_score":0.005984485,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385667651","doi":"10.1097/01.hs9.0000971208.36694.eb","title":"P1078: MOSUNETUZUMAB DEMONSTRATES DURABLE RESPONSES IN PATIENTS WITH RELAPSED AND/OR REFRACTORY FOLLICULAR LYMPHOMA WHO HAVE RECEIVED ≥2 PRIOR THERAPIES: UPDATED ANALYSIS OF A PIVOTAL PHASE II STUDY","year":2023,"lang":"en","type":"article","venue":"HemaSphere","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital; McGill University; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Refractory (planetary science); Clinical endpoint; Phases of clinical research; Surrogate endpoint; Lymphoma; Clinical trial; Oncology; Surgery; Gastroenterology","authors":[{"name":"Laurie H. Sehn","is_ca":true},{"name":"Nancy L. Bartlett","is_ca":false},{"name":"Matthew J. Matasar","is_ca":false},{"name":"Stephen J. Schuster","is_ca":false},{"name":"Sarit Assouline","is_ca":true},{"name":"John Kuruvilla","is_ca":true},{"name":"Mazyar Shadman","is_ca":false},{"name":"Chan Y. Cheah","is_ca":false},{"name":"Keith Fay","is_ca":false},{"name":"Matthew Ku","is_ca":false},{"name":"Loretta J. Nastoupil","is_ca":false},{"name":"Michael C. Wei","is_ca":false},{"name":"Shen Yin","is_ca":false},{"name":"Iris To","is_ca":false},{"name":"Nan Hu","is_ca":false},{"name":"Juliana Min","is_ca":false},{"name":"Elicia Penuel","is_ca":false},{"name":"Anton Belousov","is_ca":false},{"name":"Alexandre Coimbra","is_ca":false},{"name":"Skander Jemaa","is_ca":false},{"name":"Brendan C. Bender","is_ca":false},{"name":"David C. Turner","is_ca":false},{"name":"Lihua E. Budde","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02169060615391659,"gpt":0.3096533414890721,"spread":0.2879627353351555,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009771009,0.0003392987,0.0009290543,0.0002114232,0.0001378113,0.0006747639,0.0003491118,0.0003510226,0.001682086],"category_scores_gemma":[0.0006567186,0.0001587421,0.0005641244,0.0002579592,0.0001842831,0.0004170503,0.0001799583,0.0009061952,0.0003898736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005865012,"about_ca_system_score_gemma":0.0004383852,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004422988,"about_ca_topic_score_gemma":0.001733615,"domain_scores_codex":[0.9997697,0.00007722718,0.00002372207,0.00004076131,0.00004251444,0.00004603835],"domain_scores_gemma":[0.999666,0.00008095586,0.0001195309,0.00002286337,0.00003113074,0.0000795529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1331526,0.004800957,0.0704414,0.001964914,0.002586771,0.0007763781,0.0003424549,0.002247296,0.07938879,0.000277676,0.01125665,0.6927641],"study_design_scores_gemma":[0.1414912,0.3087443,0.4494673,0.000563079,0.006361919,0.007853323,0.000351212,0.007099793,0.0274545,0.0005090071,0.04998707,0.0001173519],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857211,0.01055157,0.0003522516,0.0003662698,0.00004552147,0.0002189889,0.0006188751,0.00007677088,0.002048769],"genre_scores_gemma":[0.9939395,0.003181577,0.0004290261,0.0003207964,0.00006644619,0.0001116257,0.001201913,0.00001227191,0.0007366924],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001682086,"threshold_uncertainty_score":0.005627096,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}